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SUWMRY 
This thesis represents an appraisal of the 
75
Se labelled selenoamino acids, 
75
Se - selenomethionine and 
75
Se - selenocystine, as pancreatic scanning agents 
and their value in the diagnosis of pancreatic disease. 
Th I d bno I 
75s I h. • · e norma an a rma e - se enomet 1onane pancreatic scan was 
assessed in a study of 200 patients. The state of the pancreas was assessed 
clinically and wy a variety of biochemical and radiological procedures. The tests 
performed varied from patient to patient. However, direct visualisation of the 
pancreas was considered the most certain way of confirming the scan observations 
and this was done in 104 (52%) patients at laparotomy or autopsy. The feature: 
of the normal and abnormal scan are presented. In general a wide variety of 
disease processes associated with a reduction of pancreatic exocrine function are 
likely to diminish uptake of 
75
Se - selenomethionine by the pancreas. _The 
majority of scans do not offer a definitive pathological diagnosis on the features 
of the scan alone. In a controlled study of the final 40 consecutive patients 
scanned, it was found that the diagnostic accuracy of pancreatic scan reporting 
may be greater than 90% in determining whether the pancreas is "normal" or 
"abnormal". The criteria for this assessment were determined by prior study of 
the first 160 patients in the series. 
Observations based on whole-body counting, organ distribution studies 
and abdominal scans in rabbits and in human subjects injected with 
75
Se - sel-
enocystine, showed that a large fraction of the injected isotope is rapidly excreted 
by the kidneys. This results in a strong renogram effect on the scan and because 
the tail of the pancreas consistently overlaps the upper pole of the left kidney, 
renal uptake of the isotope will tend to mask changes in the overlying tail of 
pancreas. For this reason it is unlikely that 
75Se - selenocystine will be as 
• r 75S I h· . f. • • sat1sractory as e - se enomet 1onane or pancreatac s-cannang. 
ii 
Techniques of enhancing 
75
Se - selenomethionine uptake by the pancreas 
are reviewed. An attempt to potentiate isotope uptake by the preparatory oral 
administration of purified soybean trypsin inhibitor in a further · 30 patients was 
unsuccessful. The rationale of this approach is discussed. 
tt · I d d th t 
75s I th· · ·· · · as cone u e a e - se enome 1onine pancreatic scanning as 
likely to become an important investigation in screening patients for the presence 
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A REVIEW OF ATTEMPTS AT PANCREATIC VISUALISATION 
The pancreas is one bf•the most inaccessible organs of the body 
and the diagnosis of the presence of pancreatic disease, particularly 
neoplasio and chronic pancreatitis, has remained a difficult and 
generalJy unrewarding challenge in clinical medicine. Its demonstration 
in everyday clinical practice depends mainly on the deplocements it 
produces of adiacent viscera such as the stomach, duedenum or kidney. 
A barium meal or pyelogram may provide indirect evidence of the presence 
of pancreatic disease. 
Numerous attempts have been made to discover a simple technique 
of direct visualisation of the pancreas. In this ,,chapter a review will be 
undertaken of the various attempts that hove been made to opacify the 
pancreas. 
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Port 1. The Search for a "Pancreas Specific" Agent 
a) Dyes 
Following the observation of Crandall, O ldberg and Ivy (1929) 
that various dyes may concentrate in the pancreas, Ingraham and 
Visscher (1935) studied the excretion of industrial dyes from pancreatic 
fistulae in anaesthetised dogs. They grouped the dyes according to 
their electrochemical characteristics by determining the direction in 
which chromogen-bearing ions migrated in an electric field. This 
enabled them to discover that predominantly acid dyes, with the 
chromogen in the onion, appeared in the pancreatic juice. Wool 
blue G, fast fuchsin B, rhodamine B, acridine red, indigo carmine, 
eosin BS, basic fuchsin, flourescein and methyl red were excreted 
from the pancreatic duct in amounts varying from 0.5 to 5% of the 
blood concentration within a very short period. Acridine red and 
rhodamine B, though classified as basic dyes industrially, were found 
by the authors to be amphoteric in that they migrated partially to 
anode and partially to cathode. 
In 1959 White and Magee attempted to exploit this information 
by opacifying the pancreas with the use of iodonated dyes. These 
a,uthors found that acridine red appeared in pancreatic fistula cath-
eters in dogs almost immedi~tely after its intravenous injection. 
Simple iodination of acridi.ne red markedly lessened. its solubility 
but it still appeared promptly in the catheters. However, an area 
of opacity seen on x-ray was found to lie outside the pancreatic area 
when checked with metal markers. This led them to abandon their 
investigations with this substance. Similar results were obtained 
with a four-atom iodonated compound of acridine orange. The main 
problems to emerge were:-
i) the insolubHity of the halogenated dyes made intravenous 
administration difficult if not impossible; 
4 
ii) the four-atom iodonated organic compounds particularly 
those of pyonin 8 were highly toxic to dogs; 
iii) iodination of the molecule appeared to change its.properties 
sufficiently to interfere with the ability of the pancreas to concentrate 
or excrete the dye. 
In 1964, Desgrez, LeDoux-Lebard, Heitz,, Atlon, Rosier, Behar 
and Aries reported the successful opacification of the pancreas by a 
tetra iodinated dye Erythrasine B. This compound is identical in 
structure ,to eosin, differing only in that the bromine in eosin is sub-
stituted by iodine. It is soluble in both water and alcohol. These 
autho11 found they could obtain opacification of the pancreas of the 
cat without encountering severe side effects though a later study in dogs 
by Heitz, Premont, LeDoux-Lebard, Atlon, Behar, Leroy, Rosier.f,.enou, 
and Leger (1965) describetl the development of photosensitivities and 
urticaria following the intravenous iniection of Erythrosine B. The 
physical characteristics and relatively low toxicity of this compound 
make it much more suitable than the iodinated dyes and metals 
previously studied for parenteral administration. However much more 
work will have to be done in order to confirm these studies and to 














f i • 1 • J: ri related olkaloi pre i y 
S.i J (1955) for tic localisation. 
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b) Alkaloids 
In 1955, Nardi and Seipal found that e subcutaneous in;ection 
of berberine, an alkaloid obtained by alcoholic extraction of Colombo 
root (Hydrastis) localized in the pancreas of rats and mice. The 
compound was detected in the pancreas 4 to 6 hours after adminis-
stration by its characteristic bright yellow flourescence in ultra-violet 
li.ght. No flovrescence was noted in any other tissue. Twenty of the 
22 berberine injected animals were found to have a high percentage ·of 
the in;ected dose (20 - 70%) in the panceas. They then went on to 
prepare some of the other related alkaloids (Fig. 1. 1. ). Columbine, 
Polmatine ond Berberine have a similar nuclear structure and differed 
only in their side chains. All yielded brilliant flourescence of the 
pancreas after parenteral iniection. Tetrahydroberberine and tetra-
hydropalmatine have an identical nuclear structure differing from the 
parent compound only in the saturation of the second phenolic ring i.e. 
they are tetrahydro derivatives. The studies suggested that the nuclear 
structure of these compounds rather than their side chains was the impor-
tant factor in pancreatic localization. 
Iodination of the nuclear structure was attempted in 1960 by 
Blau and Bender who synthesized label led berberine according to the 
scheme shown in Fig. 1. 2. Rats were sacrificed 30 minutes to 24 hours 
after subcutaneous or intravenous injection of the label led berberina and 
7 
the pancreas assayed. No more than 1% of the iniected dose was located , 1 "'1-· 
in the pancreas. Tissue extracts were examined spectrophotometrically 
and by flourescent microscopy. By the latter technique flourescence 

























































































































































White and Magee (1959) in a limited study in two dogs failed 
to demonstrate berberine flourescence in the pancreas. Subsequently 
Rubaum and Shohl (1961) had no success with berberine in 6 dogs and 
could demonstrate only faint flourescence of the pancreas in rabbits. 
As a result of these studies the observations of Nardi and Seipal have 
fallen into disrepute. It is not clear why other worken have completely 
failed to repa:,duce their apparently clear-cut results. It may be a 
question of species difference. Nardi and Seipal used mice whereas 
other workers have used rats, dogs and rabbits. In addition the process 
of iodination may change the physical properties of the compound 
sufficiently to alter its biological behaviour. 
9 
c) Antibiotics and Chemotherapeutic Agents. 
Howard, Pulaski and Fusillo (1952) studied the pancreatic 
secretion of antibiotics and sulphodiazine in man and reported that sul-
phadiazine appeared promptly in the pancreatic juice. Initially the 
concentration in the juice was approximately equal to that in the serum. 
Sodium penicillin olso appeared in therapeutic concentrations but 
streptomycin, aureomycin, terramycin, chloramphenicol and polymyxin 
were excreted poorly. This observation hos been confirmed by Johnson 
and Peskin (1965) with an iodinated preparation of sulphadiazine but 
no further information is given by these authors besides the statement 
of this fact. 
As port of a larger study on the pancreatic localisation of 
various radioactive heavy - · metal compounds Meschan, QuiM, Witcofski 
and Hosick (1959) reported that zinc sulphadiazine ( 
65
zn ) localized 
poorly in the pancreas. 
1 0 
d) Heavy Metals 
Zinc 
,,. 
In 1927 Drinker, ·Thompson and Marsh reported' the · accumu-
lation of zinc In the pancreas, ·liver, gall-bladder and kidney of cats 
fed dietary supplements of zinc 'oxide.· The pancreatic content wok 
particularly impressive 'being 10 to 20 times that found in cbhtrol · · · 
animals. In 3 of 10 cats, there was an associated heavy fibrous change 
in the acinar tissue of the pancreas.· These observations were ·s~bstan-
. tiated by Scott and' Fisher· in 1938 who fed cats a zinc·suppfemented 
diet for 3 to 4 months dnd noted that the pancreas became hard, gritty 
and fibrotic. The islets appeared to be unaffected. 
In more detailed distribution studies of the metabolism of zinc 
utilising the radioactive isotope . 
65zn, Sheline, Chaikoff, Jones and 
Montgomery (1943) showed the percentage concentration to be highest 
in the pancreas, followed by' the liver and kidney. The distribution 
pattern was similar in mouse and dog. After a single injection about 
11% of the zinc was eliminated by the external secretion of the pancreas 
over a period of fourteen days. This observation suggested that ·zinc 
probably accumulated in the acinar tells and was excreted gradually 
in the pancreatic iuice. 
In an attempt to exploit the tendency of zinc to accumulate 
in the pancreas Shapiro (1957) prepared a number of halogenated zinc 
compounds which he tested in rabbits. Although 'he achieved a limited 
success in producing_ opocification of the pancreas· he was discouraged 
from further study for a number of reasons: -
1 1 
i) All the tetra-iodinated organic compounds studied showed 
pronounced toxicity; 
ii) Most of the organic alogenoted zinc derivatives studied were 
unstable, tending to precipitate out; 
i i) All heavy metals, including zinc were toxic in ionic form in 
the concentrations necessary to produce satisfactory radio-opacification. 
Unfortunately the author gave no chemical details of the halogenated 
zinc derivatives which he administered. It is of interest that the 
problems of toxicity and insolubility are very similar to those encount-
ered when attempting to halogenate dyes. 
Manganese 
Sheppard, Wells, Hahn and Goodell (1947) showed that after 
a single injection of 
54 
Mn - manganous chloride in the dog, moderate 
concentrations were located in the pancreas. This observation was 
confirmed by Burnett, Bigelow, Kimball and Sheppard (1952) in the 
mouse and dog, though in rats the concentration in the pancreas was 
found to bexceed that of the I iver by at least three fold, the peak 
height in bott~uivalent to about 6% of the injected dose. 
In an attempt to visualize the pancreas Meschan, Quinn, 




Mn); zinc ·chloride (
65
Zn); zinc sulphadiazine (
65
Zn) and a zinc 
complex of 31 and 6' aminoflourescein. After a single intravenous 
injection of about 100/-'Ci of the compound, external counts were 





zn 3• or 61 aminoflourescein closely resembled 
those of inorganic Zn. The curve for zinc resembled the manganese 
1 2 
• 
curve but the former showed a greater pancreatic activity. However 
the authors concluded that scintiscan studies were not of sufficient 
detail to be applicable either clinically or experimentally. 
Part 2. Islet - Cell Opacifi.cation 
In their review on pancreatic visualisation Peskin and Johnson 
{1965) stated that unsuccessful attempts had been made to opacify the 
islets of Langerhans through hologenation of alloxan. Apart from the 
practical difficulties associated with the use of alloxan, Shapiro 
(195n stressed that it was unsound theoretically; the islet cell mass 
comprises only 2 - 3% of the total pancreatic mass and is not uniform 
in distribution throughout the pancreatic parenchymo. 
i 5. -=: 
,, 
Part 3. Radiological Procedures 
o) Direct T echniqves 
i) lntraductal Contrast Medium 
Direct intraductal injection of contr05t media was first performed 
by Doubilet and Mulholland in 1947 but only reported in 1955. These 
authors obtained opacification of the pancreas by injecting 70% 
Diodrost (Diodine) through polyvinyl tubing placed in the main pan-
creatic duct at operation. They noted that opacificotion of the pancreas 
tissue occurred only in the presence of acute inflammation and tha't in 
its absence the ducts alone were visualised. This technique provided 
o meons of assessing more precisely the st:Ote of the pancreas at operation 
but it carried the definite risk of inducing an attack of aeute pancrea-
titis. A variation introduced by Hayes (1960) involved the injection 
of contrast medium through a polythene catheter placed in the cystic 
duct at the time of cholecystectomy. To obtain o pancreatogrom, 
10 15 mgs. of morphine was in;ected intravenously 10 seconds before 
the introduction of 10 ml. of radio - opaque medium. This resulted 
in reflux of the medium into the pancreatic duct due to spasm of the 
Sphincter of Oddi. The author claimed to have obtained 14 good 
quaHty pancreotograms in 18 patients of which 3 had demonstrable 
disease. Utilising the some principle, Silverman and Hill (1963) 
iniected cholografin (lodipamide methylglucamine) intravenously 
and 2! hours later 15 - 20 mgs. of morphine. Twenty minute, after 
the morphine 75 u of cholecystokinin was injected intravenously and 
serial plain films and tomograms were taken ofter 45 minutes. Visual-
isation of the pancreatic duct was not accomplished in any subject. 
Extrusion of the dye through the sphincter was the rule. 
1 7 
In 1965, Rabinov and Simon accomplished the remarkable feat of 
peroral cannulation of the Ampulla of Vater, achieved with a specially 
designed duodenal tube. In the patient described they achieved satis-
factory opacification of the common bile duct and the main pancreatic 
duct. It is undoubtedly significant that their technique failed in seven 
other patients suffering from a variety of pancreatico - biliary diseases. 
These authors hove demonstrated that it is possible to cannulate the Ampulla 
of Voter perorally but with available t4chniques the almost certain prospect 
of failure is sufficient to discourage most radiologists from even trying. 
In 1967 Waldron, Bragg, Daly and Seamon working on dogs, 
placed intraluminal balloons in the duodenum to isolate the segment con-
taining the opening of the biliary and pancreatic ducts. Reflux of contrast 
medium was effected from Hle duodenum into the biliary and pancreatic 
duct systems using aminophylline introvenously and Xylocaine (Lidocaine 
hydrochloride) locally in the isolated portion of the duodenum. They had 
greater success in filling the biliary system ( 5 out of 7 times) than they 
did the pancreatic duct ( 2 out of 7 times). However it has yet to be 
demonstrated that a similar technique may be successfully applied to 
humans. 
ii) Angiography 
Per Odman's (1958) study of selective angiography of the coeliac 
artery is probably the finest study to date on visceral angiography including 
the pancreas. It is apparent from his work that meaningful results require 
considerable skill and experience as well as specialised equipment. 
In 1959 McCune and Stanbro attempted to improve the 'd nteriogrpphic 
1 8 
demonstration of the pancreas by increasing the permeability of the pan-
creatic vasculature. They baself their experiments on the earlier work 
of Stein, Powers and Browne (1956) who demonstrated Indian ink staining 
of the interlobulcar stroma, of the pancreas following intravenous injection 
of Trypsin. Indian ink alone had no effect. McCune and Stanbro injected 
1 to 10 mg. of crystalline trypsin and Indian ink into the pancreotico -
duodenal artery of anaesthetised mongrel dogs. Within 5 to 20 seconds 
there was. visible darkening of the pancreas. Provided the dose of 
Trypsin injected was kept below 5 mgs., pancreatitis and ,vascular thrombosis 
was avoided. The experiments were then repeated with 90% hypaque 
(Oiatriz:oate sodium). Diffuse opacification of the pancreas was obtained 
and the degree of visualisation increased for up to 30 minutes after injection. 
Injection of contrast medium alone produced a simple arteriogram of the 
pancreatic vessels. Intra - aortic injection of trypsin and contrast medium 
a&o~e 
with the catheter tip pmced 3 centimetres aaa-• the site of origin of the 
hepatic artery resulted in some opacification of the pancreas in 70% of 
16 dogs. The potentially dangerous side effects of intra-arterial injection 
of trypsin has deterred the use of this technique in humans. 
Boijsen (1968) studied the effects of adrenaline and bradykinin 
iniection on the pancreatic vasculature. Selective coeliac and superior 
mesenteric angiograrns were performed before and after infusion of 
adrenalin and bradyknin into these vessels. Bradykinin caused o marked 
increase of flow through all vasculature beds within the coeliac and 
superior mesenteric territories and th11s also through the pancreatic arteries. 
The angiographic detail was poor after bradykinin as a consequence of the 
increased flow. Adrenalil\on the other hand, caused a marked construc-
tion of gastric, splenic and hepatic arteries while the pancreatic vessels 
dilated. Although the flow of contrast medium through the pancreas 
appeared more rapid, the angiographic detail was definitely enhanced. 
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iii) Transverse Axial Stratigraphy 
G iraud, Bret and Gostaz {1954) employed the technique of 
transverse axial stratigraphy in the examination of the pancreas. Retro-
peritoneal and gastric insufflation provided the contrast, the pancreatic 
image being visible on sag ital exr:,osure as an oval, . triogular or pyriform 
density. Optimum clarity was usually obtained by vertical tomography, 
taking "cuts"-at different levels. The authors stressed that the technique 
had special value in lesions of the body and tail of the pancreas. However, 
like angiography it would require considerable experience' for accurate 
interpretation of the picture obtained. 
20 
b) Indirect Techniques 
i) Barium Meal 
Barium meal examination of the upper gastro - intestinal tract 
has remained the mainstay of radiological examination of the pancreas in 
general clinical practice from the earliest reports in· the second decade 
of this century (Domer 1915; Case 1916) up to the present time (Salik 
1961; Poppel 1954). This approach is unfortunately an indirect one and 
will only reveal grosser forms of pancreatic pathology. In addition, the 
signs of underlying pancreatic disease demonstrated by barium meal tend 
to be non-specific, a fact emphasised by Frostberg in 1938 in his classical 
description of the inverted "3" sign, occurring in eases of Vaterian and 
pancreatic carcinoma. However with attention to more subtle detdil 
Salik was able to claim a diagnostic accuracy of 77% out of a series of 
64 patients with pancreatic carcinoma. This must represent one of the 
more successful diagnostic series as Berk and Haubrich (1965) in a review 
of 9 published reports on bariumstudy in c:orcinoma of the pancreas found 
a 43.8% mean success rate out of a total of 810 cases. This latter figure 
is probably more represlmtative of the diagnostic accuracy of barium meal 
in carcinoma of the pancreas in the less specialised institutions. 
The value of barium studies in pancreatitis is much more difficult 
to determine accurately. However at•ntion to more subtle radiological 
changes emphasised in recent years by Poppel (1954) will increase the 
diagnostic value of this procedure. With considerable experience in the 
radiology of pancreotitis Poppel has emphasised the value of duodenal 
mucosal oedema (including the "papillary sign" due to oedema of the 
papilla at the . :.\mpulla of Vater), doudenal irritability, widening of the 
2 1 
duodenal loop and pressure on the inner concave border of the duodenum. 
ii) Percutaneous Splenoeortography 
In 1955 Figley, Fry, Orebaugh and Pollard observed that 
percutaneous splenoportography was of value in assessing disease of the 
pancreas. Thrombosi.s or distortions of the splenic vein could occur in 
pancreatitis, carcinoma or with pseudocysts of the pancreas. 
iii) Pyelography 
Various case reports have appeared from time to time describing 
pyelographic changes due to prlmary pancreatic disease {Ormond, 
Wadsworth and Morley, 194~ Chamberlein and Imber, 1954). 
2 21 
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Part 4. Conclusions 
' ' 
,., 
The acknowledged poor prognosis following the diagnosis of 
pancreatic carcinoma, excluding ampullory carcinoma (Avery Jones and 
Gummer, 1960) must reflect in part at least the inadequacy of the 
available diagnostic techniques. For example, of 100 patients with 
pancreatic carcinoma followed by Burk and Haubrich (1965) only 5 
patients survived 18 months from the time of diagnosis. 
In the last resort the clinician has still to depend in most cases 
on barium meal changes for visible evidence of pancreatic disease. If 
the clinical suspicion of pancreatic disease is sufficiently strong and 
particularly if carcinoma is suspected, arteriogmphy may be-attempted. 
However a laparotomy is often the next diagnostic step as even angio-
graphy may be uninformative. 
The use of pancreatic function tests and cytology may be of value 
in experienced hands but these too may be misleading. 
The advent of a method for pancreatic scanning (Blau, Manske and 
Bender, 1962) offered the hope of a simple procedure, caus.ing very little 




PHANTOM PAN CREA TIC STUDIES 
Phantom studies were undertaken under simulated conditions in order 
to calculate the effects of a number of variables upon the pancreatic scan. 
The information derived from these studies would assist both in helping to 





and in interpretation of the pancreatic scan. 
As a retroperitoneal organ the pancreas is generally thought to be 
immobile. On theoretical grounds at least, this immobility of the pancreas 
on the posterior abdominal wall plus the fact that it is a thin organ should 
enhance the diagnostic value of a scan provided the isotope uptake by normal 
pancreatic tissue is sufficient to be detected from the body surface. A thin 
organ in one plane, situated at the optimum focal distance to the scanning head 
should permit optimum assessment of the state of that organ. With displace-
ments of any part of the pancreas cephi lad or candad the organ wou Id sti 11 
retain the same plane (with the patient supine) and therefore remain in focus 
of the scanning collimator. However there are situations in which the optimal 
distance between the collimator and the pancreas is likely to be disturbed. 
Even with a focussing collimator the count rate from a radioactive source in 
the body falls off sharply as the depth of the source is increased. Thus if part 
of the pancreas (for example, head or tail) is situated at a greater depth in the 
body than the rest of the organ through displacement the impression might falsely 
arise of poor uptake in that port even if the activity were uniformly distributed 
throughout the pancreas. Also, in an obese patient the pancreas - collimator 
distance may perforce be greater than the desired optimum. The whole pancreas 
would therefore be ou.t1of focus. 
27 
Part 1. Ai ms of Study 
The principal aims of this study were:-
i) To determine the optimum machine settings on the scanner (to be used for 
the clinical studies to be reported) for scanning of the isotope 75Selenium 
75 · 
( Se); and 
ii) To study the effects of variation of the position of part or the whole of the 
pancreas on the pancreatic scan. 
28 
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Part 2. Materiol 
Fi .2.1: erspex oncinrom 
rizont I s 
metre distance. 
t 1 centi-
i • Scanning N.achine 
The scans were performed with the Picker Magna Scanner V (Picker 
X-Ray Corporation, New York) (Fig .3 . 2 ) which has a 12.5 cm . diameter 
thalium activated Sodium Iodide crystal and prints out the scan record both as 
an eight - colour dot scan and as a "photoscan" recorded on standard 36 x 
43 cm . x-ray fiJm . An 85 hole collimator of nominal focal length 12 cm. 
and a scannind speed of 24 an ./minute were used for the phantom studies. 
ii) Phantom Pancreas 
A phantom pancreas and stand (Fig . 2 . I ) were constructed out of 
perspex. 
The phantom (Fig . 2. 1. ) rne05ured 13! cm . along its long axis and 
5! cm. across the widest part of the head at right angles to the long axis 
(cavity measurements) . The lumen was 1 cm. thick . Two perspex screws, 
at the tip of the tail and 0,1 the inferior margin of the head, permitted e05y 
filling of the phantom with solution . The capacity when full being 50 ml . 
J f 
of water . It was attached to the ver ical ,tand by a perspex connection which 
,permits rotation of the body of the phantom around an axis running in the line 
of the connecting piece (Fig. 2 . 2 ) • Thus while maintaining the same level 
the head of the pancreas may be raised while the tail is lowered and vice verso . 
In addition the level of the phantom may be adjusted on the vertical stand 
which is marked at centimeter intervals (Fig . 2 . I ) . 
iii ) 
75
Se - Selenomethionine 
The selenoamino acid, 
75
Se - selenomethionine was used. This was 
obtained from "The Radiochemical Centre" , Amersham . The radioisotopic 


























































































emitting isotopes had been detected in the freshly prepared material, or in 
old stocks which had decayed for more than 2 half- lives. 
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i) 75 To Determine· the . Gamma - Energy Spectrum of Se on the 
Picker Magna Scanner V 
A sealed bottle containing 10.r- Ci of 
75
Se - selenomethionine was 
placed at 12.5 cm. from the collimator in its long axis . The high voltage 
applied to the photomultiplier of the scanner had previously been adjusted 
so that the threshold and channel width scales of the pulse height analyser 
section of the machine could be read directly in keV . The channel width 
was set at 20 keV and readings were taken of the count rate (in counts per 
minute read from the ratemeter display) at threshold values from 40 to 320 keV . 
Taking the highest single reading as 100% a graph was plotted of the variation 
of count rate with threshold setting or, in effect, the gamma - ray energy 
spectrum 
75
se (Fig . 2 . 3 ) • 
A similar spectrum was determined for 
198
Au . The significance of 
this is explained in Chapter 3 under "198Au - colloid gold liver scans" . 
ii) To Determine, a) The Optimum Gamma - Energy Spectrum for Pancrea-
tic Scanning, and b) The Effect of Increased Collimator - Pancreas 
Distance on the Appearance of the Scan . 
The phantom pancreas was filled with a solution containing approx-
imately 20 ,>A Ci of 
75
se - selenomethionine . This would correspond to Sok 
of an average adult dose of 2.5014 Ci and probably represents the portion 
3 
taken up by the human pancreas under optimum conditions (Chapter 3) . The 
phantom was placed in a water - bath as illustrated diagrammatically in Fig .2 . 1,- • 
The water would absorb some of the radiation emitted by the isotope, thus 


























































































































a) For the first part of the experiment the pancreas was placed at an 
optimal distance of 12! cm. from the collimator. The distance from the 
immersed phantom to the water surface was 8! cm. and from the water surface 
to the scanner head, 4 cm.. The scanner was run at 24 cm./minute. Two 
scans were performed. In the first the machine was set to detect only radia-
tion of energies between 220 to 320 keV. The second scan was repeated 
under identical conditions but the settings were changed to 100 - 320 keV. 
On the first scan the higher energy peak alone was detected. On the second, 
both energy peaks were utilised. 
b) (i) To determine the effect of increased distance between the pancreas 
and the scanner head the phantom was lowered 6 cm. in the water bath. 
This increased the collimator - pancreas distance to 18 cm. and the pancreas 
to water - surface distance to 14 cm.. Two scans were performed at the 
same two machine energy settings described above. 
b) (ii) To assess the influence of displacement of the pancreas on the scan 
38 
the phantom was placed in the water - bath at a distance of 10 cm. from the 
collimator and 6 cm. from the water surface (Fig.2.,,__ ). The scanner was 
set to detect radiation of energies between 220 keV and 320 keV. The 
pancreas was scanned at 24 cm./minute in the horizontal position (Fig.2. 7 ), 
with the head of the pancreas tilted up by 4s' (Fig.2. 8 ) and with the 
tail of the pancreas tilted up by 41' (Fig.2. ~ ). 
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Port 4. Results 
z.o - :,2o lteV I'll\, 
,oo-3ao ltc.V 
Fig.2.51 ~.38 
1. The gamma .:. energy spectrum of 
75
se recorded on the Picker 
Magna Scanner V. 
The graph depicting the energy level on different machine settings is 
shown in fig.2. 3 The results for 
198
Au are shown on the same graph. 
It can be seen that the two maxin.,m peaks for 75Se coincide with the 110 
and 240 keV energy levels. 
198 The maximum Au energy peak occurs at 400 keV. 
2. The results of the pancreatic scan at different energy levels and the 
effects of varying the pancreatic - collimator distances will be 
presented together. 
In Fig.2. 5 with the pancreas at an optimal distance of 12 cm. 
from the collimator, the scan is well shown with both sets of energy settings. 
However, the pancreatic image on the 100 - 320 keV machine settings is ' 
considerably enhanced (Fig.2.S lower) when compared to the image on the 
220 - 320 keV settings (Fig.2. 5 upper). 
With the phantom at 18 cm. from the collimator the pancreatic image 
is much better recorded on the 100 - 320 keV settings (Fig.2. b lower) 
than it is with the 220 - 320 keV settings (Fig.2. b upper). 
In tilting the phantom the altered pancreatic image recorded is clearly 
depicted in the colour scans shown in fig.2. 8 and Fig.2. 'J 
4, 1 
(1 C 
Fig.2.6: Pcage JB . 
4 ,3 
(Head Tail I 
Fig.2.7: Colour-scan of phantom in the horizontal position. 
Machine settings 220 to 320 keV. Page JS b)ii. 
Fi .2.8: Colour scan f tom with head tilhtd up 45'. 
(Machine •ttinga _. as Fig.2.7.) 
Page JS b)ii. 
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Fig.2.9: Colour scan of phantom with the toil f the pancreas 




Part 5. Discussion 
On the 6asfs.of these- results .it was dedded that all ~tients (unless 
very obese) would be scanned with the machine settings of 220 to 320 keV. 
This decision was based on the following reasoning. Firstly, with the pancreas 
being a fairly deep seated organ the higher energy peak (Fig.2.3 ) was likely 
to give a better scan impression than would the lower peak. Under optimum 
conditions, the inevitable uptake of 
75
Se - selenomethionine by the adjacent 
liver would, on the brood 100 to 320 keV machine settings, be associated 
with much greater scatter. This it was felt would tend to reduce the clarity 
of the pancreatic image. In addition the inevitably higher count rate from the 
100 to 320 keV settings could obscure a small lesion in the pancreatic paren-
chymo. The difference in image density at the different energy setting is 
strikingly apparent in fig.2. 5 The narrow 220 to 320 keV settings gave 
a less intense but quite clear impression under optimum conditions (Fig.2. 5 ). 
With an increased distance between pancreas and collimator on the 
220 - 320 keV settings there was a striking reduction in the -intensity of the 
image (Fig.2. <> ). Under these conditions (for example, with a very obese 
patient) the pancreas may have to be scanned on the broader spectrum machine 
settings before a diagnosis of "reduced uptake" is made. 
The scan effects produced by tilting the phantom are of interest. A 
more accurate representation of events would be shown if it were possible to 
11displace 11 the head of the phantom towards the collimator without simultan-
eously displacing the tail away (or vice versa) as the pancrf!as is not a rigid 
organ. ln any case movement in a posterior direction would be limited by the 
posterior abdominal wall. However the similarity in appearance between the 
phantom scan (Fig.2. 8 )ond the patient scan 6 hours after the isotope injec-
tion, discussed in Chapter 3 (Fig.3.3b ), is striking. 
47 -
48 
Part 6 . Conclusions 
A number of simpl~ phantom studies have assisted in determining the 
effects of variation in the 
75
Se gamma energy spectrum selected for scanning 
purposes. 
The effects of the variations in the distance between port or the whole 
of the phantom pancreas and the collimator are recorded. Although the higher 
energy peak of 
75
Se was selected for the human pancreatic scan, it was 
apparent that with a large pancreatic - collimator distance, a broader setting 
which incorporates both energy peaks would be necessary. 
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CHAPTER 3 
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L - METHIONINE 75Se-L- SELENOMETHIONINE 
fig.3.l: Pa fl . 
i) Rationale of Pancreatic Scanning 
Radioisotope scanning of the pancreas provides a method of visual-
izing the pancreas in situ by surface scanning of the abdomen after the admin-
istration of a radioactive labelled amino-acid which is incorporated into the 
proteins synthesized by the pancreas (Hansson and Blau, 1963). The amino-
acid used in this study is 
75
Se - L - selenomethionine, an analogue of 





Se) (Fig.3. I ). The physiology of selenomethionine incorpor-
ation by the pancreas reflects the normal capacity of the exocrine pancreas 
for a high specific uptake of circulating amino-acids utilised in the synthesis 
of digestive enzymes. 
There have been a number of reports of high amino-acid uptake by 
the pancreas shortly after the administration of labelled amino-acids. 
(Friedberg, Tarver and Greenberg, 1948; Mc.oss, Larson and Gordon, 1949; 
Busch and Greene, 1955; Kukral, Adams and Preston, 1965; Sternberg and 
Imbach, 1967). All amino-acids tested show a high localisation in the pancreas 
1 to 3 houl'J after administration (Table 3. I ) • 
Table 3. 1 
Pancreas Localisation of Amino - Acids One Hour After 
Intravenous Administration (Blau, 1964) 
Amino Acid 
14c - L - methionine 
35S L . - - cystme 
14 
C - DL - tryptophan 
Proportion of 











Wheeler, Lukens and Gyorgy (1949) have demonstrated that this high 
rate of amino-acid incorporation is principally a reflection of functioning 
acinar tissue. These authors found that in the duct-I igated cat pancreas where 
the acinar tissue is atrophic but in which the islet cells are physiologically 
intact, incorporation of 
35s - methionine was considerably lower than in the 
normal pancreas. The pancreatic activity due to 
35s - methionine uptake 
was related to the degree of tissue atrophy and where atrophy was incomplete, 
the activity found was intermediate between that of normal and atrophic tissue. 
The principal function of the pancreatic acinar cell is the synthesis and 
secretion of digestive enzymes. 'Siekevitz and Palade (1960) have calculated 
that the rate of turnover of the zymogen protein is 10 to 20 times as great as 
that of the non-exportable ocinar cell protein. That the zymogen protein 
represents the digestive enzymes is now well established. Keller and Cohen 
(1961) for example, demonstrated that the chromatographic elution profile of 
the proteins of bovine zymogen granules is almost identical to that obtained 
with the proteins of pancreatic juice. In addition, the relative proportions 
of the protein components of the zymogen granules were strikingly similar to 
those of the pancreatic juice. 
The rapid utilization and destruction of the pancreatic digestive enzymes 
requires a rapid rate of syntheiis by the pancreas and accounts for the high 
amino acid uptake. Kukral, Adams and Preston (1965) point out that the 
pancreas, with about 2.5% of the weight, manufactures approximately the 
same amount of protein each day as do both the liver and reticulo-endothelial 
system in maintaining the blood protein levels. They calculate a daily 
pancreatic protein output of 10 to 30 Gm . assuming an average enzyme concen-
tration of l to 2 Gm. per 100 ml. (Hansson, 1959) in 1 to 1! litres of exocrine 
secretion daily. It is this large protein synthesising capacity which results 
in the "concentration" of 
75
Se - selenomethionine by the pancreas. 
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ii) Suitability of 
75
Se - Selenomethionine as a Scanning Agent 
Blau and Manske (1961) were the first to suggest that 
75
Se - seleno-
rnethionine may be a suitable agent for pancreatic scanning when they found 
a consistently high level of loaalization in the dog pancreas after intravenous 
administration. The highest quantities were found 1 to 2 hours after admini-
stration and averaged about 6% of the injected dose . None of the elements 
in the structure of amino-acids (C, N , H, 0 and S) have gamma- emitting 
isotopes with half-lives longer than a few minutes . Since external measure-
ments can only be done with gamma radiation, on amino acid derivative or 
analogue contDining such on isotope must be used . As the selenium isotope 
75
Se has the physical charoc.teristics suitable for scanning (Chapter 2 ), 
75
Se - selenomethionine can be used as a scanning agent. 
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iii) The Metabolism of Selenomethionine 
In 1957, Cowie and Cohen demonstrated that selenomethionine could 
completely replace methionine for the normal exponential growth of a methionine 
requiring mutant of Escherichia cl>li. This result was of particular signif-
ioance because it demonstrated that proteins in which methionine is replaced 
by its selenium analogue, retained their functional integrity. In vitro studies 
by Mudd and Cantoni (1957) showed that the substitution of tbe sulphur of 
methionine by selenium did not affect the activation of selenomethionine to 
Se - adenosyl - L - selenomethionine by the methionine activating enzyme 
and adenosine triphosphate. They also demonstrated that the Se - adenosyl 
derivative of selenomethionine could act as the direct donor of its methyl 
group to a suitable acceptor, thus retaining one of the most important biological 
functions of methionine. 
Evidence of chemical similarity in a more complex biological system 
was provided by Spencer and Blau (1962) who demonstrated that 75Se - seleno-
h. • I d 'd · I' • h 35s h· · d met 1onane occumu ate I enhca ly wit - met 1onrne across everte 
hompster intestinal sacs in the presence of carrier methionine. McConnell s 
and Cho (196f) suggested, on the basis of their own data, that selenomethionine 
and methionine are probably absorbed from the intestine by a common transport 
system. 
Studies by Hansson and Blau (1963) confirmed that selenomethionine 
may be utilized in mammalian protein synthesis. These authors injected 
75Se I h· · · · f" I O h d I . d - se enomet 1onme into a pancreatic 1stu a cat. n y, ro ys1s an 
subsequent chromatography of the protein in the pancreatic juice they showed 
that 85% of the initial radioactivity in the juice appeared in a single peak 
at the position of selenomethionine. The incorporation of 
75
Se - seleno-
methionine into human plasma proteins and haemoglobin has also been studied 




Dealy, 19 ) . The availoble evidence demonstrates conclusively that 
7
~se - selenomethionine may be utilised for protein synthesis in mammals . 
iv) Potential Hazards in the Use of 
75
Se - Selenomethionine 
a) Radiation Dosimetry 
75 
Estimates of the dosimetry of Se - selenomethionine in man are 
based on the data of Blau (1964). He suggested tha.t th~ pri~cipal initial 
localization of the isotope is in the pancreas (7%) and in. the liver (10%). 
The pancreatic uptake is util .iz:ed principally for the synthesis of digestive 
" ' ! ' ' 
enzymes which ore usually rapidly secreted, digested and then reabsorbed. 
Similarly, the liver upt~ke .is principally into plasma proteins being synthe-
sized at the time of injection. These then enter the general circulation. 
Blau considered tbat following ~he .initial distribution there is extensive re-
cycling of the isotope so that after the first day distribution is considered as 
essentially whole-body. His data is tabulated in Table 3,2 :-
Table 3. 3 














75 The ganwna-ray constant for Se, calculated for the 7 gamma-ray 
energies with abundance above 0.5% is 1.56r/mC - hr. at 1 cm.. In add-
ition the short range radiation from x-rays and conversion electrons has been 
· d O 0105 
75s d" · · U · h h · I estimate at • mev per e mntegrataon. sang t ese p ysaca 
and biological factors the following integrated doses were calculated by 
Blau based on a routine scanning dose of 314CVK9m.:-
5 7 
Total body dose· 
Extra dose to pancreas 
Extra dose to I iver 
Highest total body dose rate 
- 1.3 r 
= 0 .06 r 
= 0.05 r 
= 0 .11 ,/week 
The maximum permissoble radiation in man, though uncertain, is 
considered by Behrens and King (1964) to be less than 0.3 r per week. In a 
recent review of 
75
Se - selenomethionine dosimetry in man, Numerof (1966) 
quotes Blau's estimations as being the most realistic published .as other authors 
(Zuidema, Kirsh, Turcotte, Gaisford, Powers, Kowalczyk, 1964; Sodee, 1965) 
58 
have based their estimation$ on animal data. The problem related to the extra-
polation of data obtained from animals to man, is apparent when COO$idering that the 
biological half-life of 
75
Se - selenomethionine has been reported as ranging 
from 5 to 20 days in mice (Anghileri and Marques, 1965; Blau, 'Manske and 
Bender, 1962), 23 to 67days in dogs (Digiulio and Bei ltes, 1964; Sodee, 
1965) and 273 days in rhesus monkeys (Zuidema, Kirsh, Turcotte, Gaisford, 
Powers, Kowalczyk, 1964). Preliminary estimations in man have ranged from 
36 to 144 days (Sodee, 1964; Penner, 19tl>. Ben-Porath, Case and Kaplan 
(1968) using normal human volunteer subjects calculated a whole-body radiation 
dose of 1.63 r for a tracer dose of 2501ACi in a 70 Kgm. man. This appears to 
be the most comprehensive study to date and agrees fairly well with Blau•.s est-
imations. 
On the basis of Blau's (1964) data permission was granted by the Med-
ical Research Council to administer 314 Ci/Kgm. 
75
Se - selenomethionine to 
adult patients. Pregnant women and children were excluded from the study. 
b) Toxicity of Selenomethionine 
Toxicity due to inorganic selenium or the selenoamino acids has 
not yet been reported in man (Glover, 1968)** 
Klug, Moxon, Petersen and Pointer (1953) injected rats intraperi-
toneally with the selenoamino acids to determine the toxicity of these com-
pounds. They calculated the Dlso in rats to be 4.5 (! 0.3}mg. selenium 
(selenomethionine) per Kgm. body weight. In man this would represent at 
least 3,200 times the quantity administered for scanning purposes. 
Administration .of methionine is purported to be dangerous in advanced 
liver disease (Watson, 1949; Kinsell, Harper, Giese,Morgen, McCallie and 
Hess, 1 &49). However the adverse effects of methionine in patients with 
advanced liver diseose became apparent only after oral administration of 
8 to 20 grams. This is 32,000 times the tracer quantities of selenomethionine 
adminiitered in this study. In addition symptoms of portosystemic encephalo-
pathy are far more difficult to produce with intravenous administration of 
even large doses of methionine (Phear, Rbebner, Sherlock and Summerskill, 
1956). 
No adverse symptoms or signs developed in any patient in this study 
after selenomethionine injection. 
** Personal Convnunication: Or .J.R. Glover, Senior Lecturer in the 
Department of Social and Occupational Medicine, Welsh National 
School of Medicine, Cordcif. 
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Part 1 • Aims of the Study 
The two main aims of this study were:-
i) To define the normal and the abnormal pancreatic scan; and 
ii) on the basis of this experience , to assess as objectively as 
possible the diagnostic accuracy of sc:on reporting. 
The initial assessment of the normal and abnormal sc:on was based on 
a study of the first 160 patients of the total series of 200. The scans were 
viewed with a knowledge of the clinical details and investigation results in 
eac::h patient. To assess the diagnostic acc:urac:y of the scan reporting the 
last 40 consecutive scans of the series were viewed without knowledge of 
any clinical detail. To avoid bias which could result from seeing the patient, 
the patient selection and scan supervision was attended to by a col league. 
6 1 
Part 2. Clinical Material 
· The clinical diagnosis of the 200 patients in this study are tabulated 
in Table 3.3 
a) Classification 
The patients have been classified into 3 main groups:-
Group l ~ Normal Pancreas 
These patients were referred for a pancreatic scan to try and exclude 
occult pancreatic disease, particularly carcinoma. Many of the patients 
in this group suffered from anxiety states or depression with vague symptoms 
referable to the upper abdomen and weight loss. A number of patients with 
unexplained venous thrombosis and pyrexia of uncertain origin are included 
in this group. 
Group 2: Pancreatic Disease 
This group included patients suffering from a variety of disease states 
directly involving the pancreas. Patients suffering from systemic disease 
with definite pancreatic involvement such as diabetes mellitus, fibrocystic 
disease and from amyloidosis were included . 
Group 3: Extrapancreatic Disease 
This group was comprised of patients either suffering from a disease 
state commonly considered in the differential dia9i1osis of pancreotic disease 
eg . - cholelithiasis or obstructive jaundice, or from a condition which was 
likely to influence pancreatic function eg. - gastroenterostomy or vagotomy . 
6 ,3 . 
TABLE 3.3 
TABULATION OF THE 200 PATIENTS SCANNED WITH 
75
se - SELENOMETHIONINE 
ACCORDING TO CLINICAL DIAGl'-JOSIS 
CLINICAL DIAGNOSIS 
1. NORMAL 




iii ) Metastatic 




c) Pseudopancreatic Cyst 
d) Diabetes Mellitus 
e) Partial Pancreatectomy 
f) Fibroc ys tic Disease 
g) Amyloid Disease 
Total 
3. EXTRAPANCREATIC DISEASE 
a) lntrahepatic Cholestasis 
b) Bile - Duct Carcinoma 
c) Cholelithiasis 
d) Peptic Ulcer 
e) Gastrectomy, Gastroenterostomy and Vagotomy 
f) Aortic Aneurysm 
g) Sarcoidosis 






















6 4 . 
b) Diagnostic Assessment 
The picture presented by the pancreatic scan would be most accur-
ately confirmed by inspecting the pancreas in situ. For this reason in the 
initial assessment of the normal and abnormal pancreatic scan, the selection 
of patients for scanning was influenced by whether or not they were likely 
to come to loparotomy anyway. Operative or autopsy confirmation of the 
state of the pancreas was obtained in 10f (st%) cases. The breakdown 
of the diagnostic categories is presented in Table 3. At- This permitted 
an exact assessment of the position of the pancreas, the presence or absence 
of pancreatic pathology and the degree of hepatic - pancreatic overlap, 
in the majority of cases. In addition, the poa:reos was assessed clinically; 
by relevant biochemical tests such as the glucose tolerance test, faecal fat 
estimation and secretion stimulation with duodenal aspiration; and by 
radiological procedures such as barium meal or selective coeliac arterio-
graphy. The tests performed varied from case to case. This study covers 
a two and a half year period and the majority of patients have been followed 
up cliniaally over this time. Therefore it i1 felt that the ovemll assessment 
of the presence or absence of significant pancreatic diseGH is probably 
accurate. 
1. The Normal Pancreas 
The pancreas wm inspected at operation in 29 of 67 patients. In 
the remaining 38 patients a variety of tests including serum amylase, faecal 
fat and glucose tolerance test estimations were performed to help exclude 
pancreatic disease. 
6 , 5 . 
TABLE 3.4 
DIRECT VISUAL CONFIRMATION OF PANCREATIC STATE 
DIAGNOSIS VISUALLY CONFIRMED GROUP TOTAL 
1. NORMAL 29 67 
2. PANCREATIC DISEASE 
Carcinoma (Al I kinds) 19 19 
Pancreatitis 
Acute 9 18 
Chronic 7 15 
Pseudopancreatic Cyst 0 2 
Diabetes Mellitus 11 
Pancreatectomy 6 6 
Fibrocystic Disease 
Amyloid 
3. EXTRAPANCREA TIC DISEASE 
lntrahepatic Cholestasis 0 5 
Bile-Duct Carcinoma 5 5 
Cholelithiasis 10 12 
Peptic Ulcer 2 14 
Gastroenterostomy 11 11 
Aortic Aneurysm 2 2 
Gardner's Syndrome 1 
Sarcoidosis 0 4 
Miscellaneous 0 6 
Totals 104 200 
2. Pancreatic Disease 
Carcinoma of the Pancreas 
In all 19 patients of this group the diagnosis was established by operative 
biopsy or resection. 
Acute Pancreati tis 
All 18 patients in this group had suffered at least one attack of acute 
pancreatitis from I week to 9 months prior to scanning. In 9 patients the diagnosis 
was confirmed at the time of the acute attack at laparotomy. In the others the 
diagnosis was made on the clinical picture and the raised serum amylase level. 
Chronic Pancreatitis 
Seven of the 15 patients in this group had qperative confirmation of an 
indurated and diseased pancreas. In all 15 patients it was possible to elicit a 
history of previous abdominal pain and in all patients either radiological 
calcification or evidence of exocrine Lnsufficiency on function testing or both, 
were present. 
Pseudopancreatic Cyst 
Two patients with pseudopancreatic cysts had the diagnosis confirmed by 
barium meal examination. 
67 
Diabetes Mel fitus 
There are II patients in this group . None of the patients had any clinical 
evidence of underlying primary pancreatic disease. All II patients in this group 
required medication either orally or systemically to control the blood sugar level. 
In I patient in this group, the pancreas was examined at laparotomy. 
Pancreotectomy 
The state of the pancreatic remnant as assessed at the time of operation 
was normal in 3 patients and involved by chronic pancreatitis in the other 3 . 
Fibrocystic Disease of the Pancreas 
This patient, o girl of 16 years died 4 months after the scan. At autopsy, 
a pancreas of nearly normal size was found to be virtually replaced by fibro-
fatty tissue. This patient also had classical pulmonary and hepatic involvement 
with portal hypertension. (Page201) 
Primary Amyloidosis 
This patient suffered from extensive neurological involvement by 
primary amyloidosis. At autopsy 8 months after the scan the pancreatic 
parenchyrna was extensively infiltrated with amyloid deposits. However the 
faecal fat content and glucose tolerance estimation were within normal limits. · 
(Pagez,>9). 
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3. Extrapancreatic Disease 
Obstructive Jaundice 
There were 10 patients in this group. All 5 patients suffering from 
carcinoma of the bile-duct underwent operation. The other 5 patients were 
suffering from cholestatic jaundice due too variety of causes suoh as primary 
biliary cirrhosis, drug hepatitis; and infectious hepatitis. · The primary hepatic 
cause for the cholestosis in these patients was confirmed by liver biqpsyand liver 
function tests. 
~. t 
Chol el ithiosis 
Of 12 patients with cholelithiasis who were scanned, 10 underwent 
operation for cholecystectomy. In none of thes e patients was pancreotitis 
suggested clinically or biochemically. 
Peptic Ulcer 
This group consisted of 14 patients with symptomatic gastric or duodenal 
ulcers, all of which had been proven on barium meal. There was no clinical 
evidence of pancreatic disease in any of these patients. In 2 patients the presence 
of complications was confirmed at operation. 
Postgastrectomy, Gastroenterostomy and Vagotomr 




Two patients had upper abdominal aortic aneurysms confirmed at 
laparotomy . 
Gardner's Syndrome 
This patient a 36 year old woman presented the c lassical features 
of Gardner's Syndrome (Gardner and Richards, 1953) clinically with 
multiple polyposis coli and duodeni , osteomas of the maxilla, sebaceous cysts 
and a large fibrotic mesenteric: mass confirmed at laparotomy. She was 
unusual in that there was no family history of polypotis coli. 
Sarcoidosis 
Of the 4 patients in this group, 3 had parotid involvement and a 
positive Kveim test . There was no clinical history of pancreatic disease 
and in all 4 patients the serum calcium was normal. 
Miscellaneous 
The 6 patients in this group s uffered from .hypothyroidism, acromegaly, 
hyperparathyroidism (2 patients) primary hyperlipidemia and coel iac disease . 
In none of this group was there clinical evidence ofi pancreatic disease . 
70 
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i) Scanning N.achine 
The scans were performed with a 511 crystal Picker Magna Scanner 
(Picker X-Ray Corporation, New York) using an 85 hole collimator of nominal 
focal length 12 cm. and a scanning speed of 24 cm./minute. A photoscan 
(Fig.3. 7 ) and coloured "scantiscan" (Fig.3. b ) was obtained on each patient 
scanned. The details of the machine settings for 
75
Se are given in Chapter 2. 
ii) 
75
Se - L - Selenomethionine 
The 
75
Se - L - selenomethionine was supplied by the Radiochemical 
Centre (Amersham) in aqueous solution which had been sterilized by auto-
claving in accordance with the requirements of the British Pharmacopoeia. 
The specific activity was 200 - 800 mc./mM. An excess of cysteamine 
hydrochloride (2 rngs./mCi) was added to each batch on arrival to act as an 
antioxidant (Blau, 1964). 
To facilitate administration the 1 mCi/ml. supplied was diluted to a 
volume of 10 ml·. with O. 9% saline and stored in sterilized rubber-topped 
dark bottles. 
iii) Patient Preparation 
This subject is discussed in Chapter 5. 
No special preparation was employed in most of the cases but the . 
patients were encouraged to take as complete a diet as possible for the few 
days preceding the investigation and a large breakfast on the morning of 
the scan. The procedure was performed on both in- and out- patients. 
iv) Procedure 
A dose of 3 t,A Ci per kilogram of body weight was injected intra-
venously. In 6 patients the isotope was administered ,subcutaneously into 
the buttocks with 1200 u of hyoluronidase. The results were as satisfactory 
as after the conventional intravenous injection. 
The position of the costal margin was marked on the skin and trans-
posed as surface markings onto the paper used for recording the colour scan. 
The pancreatic scan was begun 30 to 60 minutes after injection of 
the isotope~ 
Patients were scanned supine (Fig.3. Z. . ) or with thefr head and 
shoulders slightly elevated for comfort. Scanning was usually commenced 
at a level just above the xiphisternum. The average duration of the scan was 
40 to 50 minutes. 
A 
198
Au - colloid gold liver scan was performed in all patients for 
precise location of the liver edge. The scans were performed in this sequence 
as scattered radiation from the higher energy gamma radiation emitted by 
198
Au interfered with the 
75
Se counting (Fig~2. 8 ). The principles 
and dosimetry of 
198
Au colloid - gold liver scanning are contained in 
Appendix 3. 
v) lhe Timing of the Pancreatic Scan 
The pancreatic scan was performed 30 to 60 minutes after the injection 
of the isotope. A second scan was performed in an initial group of patients 
between 2 to 6 hours after the injection but was subsequently abandoned as 
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minutes 
Fig.3 .3 : t 6 hours fter isotope iniection. 
Early serial studies showed that the isotope label is distributed widely 
throughout the pancreatic parenchyma 30 minutes to 2 hours after the isotope 
injection (Fig. 3 . 3A ). A scan performed at 6 hours, on identical machine 
settings in the same patient showed the activity to be concentrated toward the 
centre of the body of the pancreas and then toward the head (Fig.3.3f,). This 
scan gave the erroneous impression of thinning in the tail of the pancreas. It 
was concluded that the optimum time for scanning would be when there was 
diffuse distribution of the isotope in the pancreas i.e. approximately 30 
minutes to 2 hours after injection. 
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Part 4 . Results 
I. POSITION 
2. AREA OF LOW UPTAKE 
3. BOWEL I MAGE 
4. CONVEX BORDER 
Fig.3.4: Diagrammatic representation of the main features of the 
normal pancreatic scan. 
For the sake of clarity the case records of the patients whose scans 
are used to i llustate features of the normal and abnormal scan are presented 
in Appendix 1 • 
An analysis of the reports of the pancreatic $\;ans on the 200 patients 
in this study is presented in Table 3.5 
A. The Normal Pancreas 
Th s: f h I 75s I h. • · e ,eatures o t e norma e - se enomet 1onme pancreatic scon 
are illustmted diagrammatically in the line drawing (Fig.3.'t- ). 
i) Position 
The most striking feature is the variation in the position of the body 
and tail in relation to the head. This varied from a horizontal position 
(Fig.3 .5 ) to one lying approximately45° (Fig .3.~ , 3.1 ). 
ii) Shape 
The shape of the gland varued between two common configurations; 
the neck, body and toil assumed either a straight I ine (Fig. 3 . f> ) or a 
sigmoid shape (Fig.3.S' ). 
iii) Isotope Distribution within the Pancreas 
A frequent finding is an area of decreased uptake in the vicinity of 
the neck of the gland (Fig.3.5" ). This gives the false impression of a 
filling defect. This appearance is presumed to be due to the adjacent portal 
vein compressing the pancreatic parenchyma. This particular feature sho..tl 
79 
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TABLE 3. 5 
AN ANALYSIS OF THE REPORTS OF THE PANCREATIC SCANS ON THE 
200 PATIENTS IN THIS STUDY 
CUN ICAL DIAGNOSIS SCAN REPORTS 
Normal Abnormal Unreadable Total 
1. NORtv\AL 57 4 6 67 
2. PANCREATIC DISEASE 
a) Carcinoma 
i) Primary 10 3 13 
ii) Ampvllary 3 4 
iii) Metastatic 
iv) Islet Cell (Zollinger-Ellison Syndrome) 
b) Pancreatitis 
i) Acute 7 9 2 18 
ii) Chronic 12 2 15 
c) Pseudopancreatic Cyst 2 2 
d) Diabetes Mellitus 4 6 11 
e) Partial Pancreatectomy 6 6 
f) Fibrocystic Disease 
g) Amyloid Disease 
Total 73 
3. EXTRAPANCREATIC DISEASE 
a) lntrahepatic Cholestasis 5 5 
b) Bile-Duct Carcinoma 5 5 
c) Cholelithiasis 8 4 12 
d) Peptic Ulcer 11 3 14 
e) Gastrectomy, Gastroenterostomy and Vagotomy 6 5 11 
f) Aortic Aneurysm 2 2 
g) Sarcoidosis 2 4 
h) Gardner's Syndrome 


































































































































































































































































































fi9.3.6.(Patiant I ): Colour ,cca, of• nonaol panCINI. The 
,urface 111Grlci1191 of the COltal margit11 are indiccmtcl by 
the blodc lines. 
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ith bifid head oppearancv. 
be examined critically as pathology in this region may be overlooked. For 
example, Fig.3. ZI • ilJustrates a pancreatic scan in which the area of 
"physiological thinning" is considerably enhanced without any displacement 
of Hie pancreas. This was associated with a fusiform aneurysm of the aorta 
posterior to the body of the pancreas . In Fig.3 .21,. there is a clear filling 
defect in the same area of the pancreatic scan. In this patient it IIFOS due 
to infarction of the pancreatic parenchyma following relapsing acute pancre-
atitis. 
' ' 
Another less common physiological filling defect is 'observed on the 
duodenal margin of the head and in the extreme cases this resulted in the head 
showing a distinct bifid appearance (fig .3. 9 ) . There are two main factors 
which could produce thas effect. One is the termination of the combined 
pancreatic and common bile-ducts and the other is uptake by the duodenal 
mucosa of the 
75
Se - selenomethionine. It is likely that the importance 
of either of these factors varies from patient to patient. 
iv) Uptake of 
75Se - Selenomethionine by Liver arid Bowel 
The most constant visceral uptake other than that of the poncre~ is 
by the liver and proximal small bowel . Liver uptake is a universal feature 
and a subsequent liver scan is essential to determine the precise location 
of the liver edge especially in those cases in which it is contiguous with or 
overlaps the pancreas. Thirty six of the total 67 patients in this group had 
some degree of overlap of the pancreas by the liver. This usually involved 
less than 25% of the total pancreatic area . However in these cases the scan 
was considered normal as the overlapped area showed good reinforcement of 
the hepatic shadow. In particular there was no alteration in the normal 
J»Sition or contour of the pancreas. Although such a case has not yet been 
encountered, it is conceded that a very small lesion in the overlapped area 
8 5 
fig.3. 9:(P tientJt.) of tient with diabetes Jlitu1. 
The conaidenable bowel uptake (the dotted on the inset) 
I ively I r activity in the tail of the creas 
convey the erroneous i111f>'911ion of a "horse 
ntal. 
could not be excluded. 
In 13 (6.5%) scans of the whole series the pancreatic outline was 
obscured by uptake in the overlying liver. Unless hepatomegaly is gross 
it is not always possible to predict prior to scanning whether the liver uptake 
will interfere with the pancreatic scan. In the event of overlap by the liver, 
the convex lower margin of the pancreas head is an important and useful 
91ndmark in assessing the pancreatic position (Fig .3 . 4,. ) • Provided there 
is uptake by the pancreas this convex margin invariably projected below the 
left lobe of the liver. The localization of the reinforced hepatic-pancreatic 
uptake con then be determined by its normal relationship to the head of the 
pancreas. 
The usual po1ition of visible bowel uptake is shown in fig.3 .t,-
This localization is remarkably constant in relation to the lower margin of 
the body and tai I of the pancreas and is presumed to be uptake of a fixed 
position of the bowel. This would correspond to the distal duodenum and 
proximal iejunum at the position of the ligament of Treitz. Uptake in this 
region is sometimes more impressive than in the pancreas and can give the 
87 
false impression that the tai I of the pancreas is deflected downwards (Fig .3 , 'f ) . 
Bilateral uptake of the 
75
Se - selenomethionine which may be due 
to renal uptake or excretion that has never been recognised. 
v) Reproducibility of Scans 
The reproducibility of the main anatomical features described is good. 
Six normal patients and three patients with pancreatic dise058 and abnormal 
scans had their scans repeated after an interval of 6 to 12 months. In all the 
patients the main features of both scans were similar. However uptake of 
I ,, . 
isotope in the organs did differ in relation to the functional state of the organ. 
For example, fig .3 .10"" illustates the sc:an of a patient who had suffered a 
severe c:linic:ol attack ·of ac:ute panc:reatitis 10 days previously. Pancreatic 
uptake is c:onsiderobly diminished. The patient was rescanned 10 months 
later after a full c:linic:al recovery and no further attacks. Fig.3 .101:> shows 
the considerably increased pancreatic: uptake in the same patient. 
vi) Influence of Hepatic function on the Scan 
In 2 patients with ac:tive chronic: ("lupoid11 ) hepatitis and severely 
disordered liver function tests, the pancreatic: uptake was partially obscured by 
the very high background activity . This was attributed to a failure by the I iver 
to take up selenomethionine in the normal fashion. 
vii) Failure of Uptake in the Normal Pancreas 
Four patients in whom there was no evidence of pancreatic dysfunction 
had abnormal scans. All were over the age of 65 years. Two had diffuse 
atheroma of the aorta and its branches with splenic artery aneurysms on coeliac: 
artery arteriography. One patient had thyrotoxic:osis. In all patients there 
was diffuse foi lure of uptake of the isotope. 
8 9 
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The Abnormal Pancreas 
Carcinoma 
Primary Pancreatic Carcinoma 
In 10 of the 13 cases in this group the scan was definitely abnormal. 
Three patients had a circumscribed filling defect on the $Can (Fig.3, 11 }. 
In 7 patients there was more diffuse failure of isotope uptake. This was due 
9 f ·-
to co-existant pancreatitis in 2 in whom there was failure of uptake well beyond 
the limits of the tumour. In the remaining patients isotope uptake was diffusely 
poor in part or the whole of the gland depending .on the degree of infiltration 
(Fig.3.11 ). 
With an expanding lesion the adiacent normal tissue was invariably 
displaced and distorted (Fig . 3. 13 ) • However there was seldom complete absence 
of uptake in the area occupied by the tumour. 
Three patients had hepatomegaly with the pancreas completely obscured. 
The scan was of very limited value in these cases. 
ii) Carcinoma of the Ampulla of Yater 
Three out of 4 patients ahowed diffusely poor uptake of the isotopic 
label by the pancreas. The other patient had a normal scan. 
iii) Functioning of Islet-Cell Tumour 
In one case of the Zollinger - Ellison Syndrome in which the patient 
suffered recurrent bouts of abdominal pain attributed to relapsing pancreotitis, 
the pancreatic scan shows very poor uptake in the head and neck but excellent 
92 
fig.3.12:(P.tient t, ): toscan of• ient with c.arcinoaa 
of the wing o filliftQ defect of the beod, 
y toil f the panereaa. The hot or• on 
tbe hut repr.enfl the site of discemable it01i up-
t • by the pane as. 
fi .3.13: ( ati t 7 ): toscan of o patient with corci f 
th body oft e ere • The normal tic confi -
uration is diwpt by the rowth witb considerable 
displacement distortion of the ymo. 
The two croues 11 resen t surfoce dci11G5 of the 
I tercd limits of the palpable epir,astric -· Theae 
approximate well to the limits of the filling defec:t on the 
SC • 
fi9.3.14cu(Poti nt S ): Photoscan fa patient with. chronic 
er ti tis Gnd ca fu :1ctioni OC-cell carci . in the ta· J 
of the <;reel$.. The black GIN on the ir•t repreMnts 
t site of the tumour.. the .. ia foilu .. of i tope uptake 
by the Mad, ck part of the body f tt.e glond. 
The en line rep,._.tl the liver morgin. 
Fig.3.14b:(Patienf 8 ): A scan performed tfa after a 
distal pancreatectomy in the patient ffering from 
the ZollingeJ"-EllilOD Synd_. (Fig.3. t4o.). The 
area of panONtic. uplllk• i1 abeent. 
95 
uptake in the tail (Fig .3 ,1&,.a.). Because the scan density was greater at this 
point than in the middle of the right lobe of the liver, normally some 6 to 8 ems . 
thicker, it was interpreted as representing enhanced uptake of the selenometh-
ionine by the tumour tissue . At laparotomy the head, neck and tai I of the 
pancreas were fibrosed and indurated because of the co-existant pancreatitis. 
The site of maximum uptake in the tail of the pancreas coincides with the 
position of an infiltrating poorly differentiated ot - cell carcinoma of the 
islets . Distal two-thirds pancreatectomy was associated with loss of the "hot" 
a rea on a scan repeated 4 months post-operatively (Fig . 3, llf I, ) . 
iv) ~taltatic Carcinoma of the Pancreas 
A scan showing the tail of the pancreas slightly expanded was seen in 
a patient with metastatic carcinoma of the pancreas . Biopsy of the pancreas 
at laparotomy showed extensive secondary adenocarcinomatous involvement 
of the pancreatic lymphatics . The primary site was on adenocarcinoma of 
the sigmoid colon . Extensive malignant involvement of the tai I of the pancreas 
had displaced the functioning parenchyma to give a broadened appearance . 
2. Pancreatitis 
i) Acute Pancreatitis 
Of the 18 patients in this group, 9 had abnormal scans . The featu res 
are failure of isotope uptake in part (Fig . 3 .16' ) or the whole (Fig . 3 .IOa ) of 
the pancreas . Changes are generally more apparent in the head than the tail 
of the pancreas . All these 9 patients with abnormal scans had active pancre-
atic disease at the time of the scan with the classical pain and tenderness and 
raised serum amylase . The abnormal pancreatic scan was apparent for 2 to 3 






















































































































































In 7 patients the scan was normal. Significantly, at the time of 
study all of these patients were in clinical remission. The scan was performed 
within 3 to 36 weeks after a documented attack of pain. 
Recovery of pancreatic function with restoration of the scan to normality 
is documented in Figs. 3 . 10., • and 3 . 10 b • This patient WOJ described on 
page. 91 . Liver overlap prevented the interpretation of the scan in 2 out 
of the 18 patients. 
ii) Chronic Pancreatitis 
In 12 of the 15 patients in this group the scan was abnormal with gen-
eralized failure of isotope uptake (Fig. 3,16.). The diminution of isotope 
uptake can generally be related to the severity of the exocrine insufficiency. 
In 1 patient with steatorrhoea the scan was within normal limits. 
In 2 patients the scan was considered unreadable because of significant 
hepatomegaly. 
3. Paeudopancreatic Cyst 
Two patients with paeudopancreatic cysts had abnormal scans. The 
abnormality detected was an area of increased activity in relation to the body 
and tail of the pancreas (Fig.3.17 ). One patient developed the pseudocyst 
following an attack of acute pancreatitis. In the other, it arose as a result 
of surgical trauma to the pancreas at the time of splenectomy. 
4. Diabetes Ntellitus 
In 6 of the 11 patients in this group the uptake was considered to be 
98 
fig.3.16a:(Patient,S)Photoscan of a patient with calcific 
pancreati tis (F ig . 3. 1 l b), associated with excessive 
ethanol consumption. The only pancreatic uptake 
discernible is an island of activity inferior to the left 
lobe of the I iver. The isotope uptake on the right of 
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Fig . 3 . 17:(Patient)J)Photoscan of a pseudopanereatic cyst 
showing an area of increased activity overriding the 
body and toil of the pancreas (stippling on inset) . 
The Jiver is in the left hand corner and only just 
overlaps this active a rea . Uptake by the rest of the 
gland appears reduced . 
































































































































































































































































1 0 J 
decreased. One patient, o very labile insulin dependent diabetic was examined 
at laporotomy and found to have a normal pancreas (Fig.3. 'I ). The quality 
of the scan was generally poorer in insulin dependent diabetics. 
One scan was considered unreadable because of the gross overlap. 
5. Partial Pancreatectomy 
Isotope uptake was poor in the pancreatic remnant of all 6 patients in 
this group • 
6 • Fibrocystic Disease of the Pancreas 
The scan showed complete absence of uptake. This was so striking that 
the pancreas appeared as a filling defect against the normally low count rates 
of the adjacent intestine and enlarged spleen • 
7 • Primary Amyloidosis 
Uptake was considerably reduced in this patient with advanced primary 
amyloidosis. 
.. 
C. Extrapancreotic Diseases 
i) Pe ptic Ulcer 
Three out of 14 patients in this group showed abnormal scans. O ne 
patient with low pancreatic uptake was on nasogastric suction and probanthine 
for severe ulcer pain. Clinically the symptomatology was more typical of 
ulcer pain than pancreatitis and the serum amylase was normal. In the second 
patient the scan shows the tai I of the pancreas to be displaced upwards under 
the liver edge (Fig.3. ICf ). At operation this displacement was confirmed • 
It was due to contraction of fibrous scar tissue from a chronic gastric ulcer 
involving the tai I of the pancreas. In the third patient the scan shows elong-
ation, displacement and thinning of the neck of the pancreas (Fig .3.10 ). 
This patient had developed a subacute perforation of a duodenal ulcer with an 
inflammatory mass which had formed medial to and was displacing the neck of 
the pancreas. These changes were confirmed at laparotomy. 
ii) Cholelithiasis 
Four patients of the 12 in this group showed abnormal scans with 
decreased uptake of isotope. 
of the pancreas at operation. 
of the pancreas~ 
iii) Aortic Aneurysms 
Three of these patients had abnormal induration 
The accent of the pathology was in the head 
1 O 4 
Two patients had aortic aneurysms, confirmed at laparotomy, and 
abnormal scans. A filling defect in the mid-portion of the body of the pancreas 
in one patient was caused by compression by a fusiform aneurysm of the abdominal 
aorta (Fig.3 .2.I ). There is excellent pancreatic uptake and no displacement 
of gland tissue adjacent to the filling defect. 
Fig.3.19:(Patientt6} Photoscan of a patient with a chronic 
perforating gastric ulcer in whom the tail of the pancreas 
was involved by fibrous scar tissue and displaced up-








fig.3.20:(PatientJf) The head and neck of the po er as are 
compressed and displaced laterally in this photoscan 
ya mass medial to th head of the pancreas. This 
was an omentol mass whic formed in relation to a 







fig.3.21 :(Patient 11 ): This colour scan depicts a large filling 
defect in the midportion of the pancreas. It was due 
to a fu.si form aneur)'lm of the aorta compressing the 
pancreas posteriori y. 
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Fig.3.22:(Patient IS ): Photoscan of a pancreas which is displaced 
upwards under the left lobe of the liver by a large saccular 











1 0 9 
Another variation in the scan was upward displacement of the pancreas 
by an adjacent saccular aneurysm (Fig .3.22 ). Besides the very marked 
displacement the pancreas appeared otherwise normal • 
iv) Postgastrectomy, Gastroenterostomy and Vaaotomy 
In this group 6 of · 11 potients had normal 'Scans. , In 4 patients uptake 
was poor and this is particularly apparent in the head of the pancreas. 
v) Diseases Associated with Cholestatic Jaundice 
The pancreas scan WCIS normal in the 5 patients with bile-duct carcinoma 
and in the 5 patients with intrahepatic cholestosis. 
vi) "'1esenteric Fibrosis 
There was a circumscribed indentation of the neck and head of the 
pancreas in the patients. with Gardner's Syndrome . This was due to a large 
fibrotic mesenteric mass indenting the pancreatic parenchyma . 
vii) Sarcoidosis 
There were 4 patients in this group. In 3 patients with parottd) 
involvement and a positive Kveim test, uptake WQSlllormaJ in one and 
abnormally low in 2 • 
Jn 1 patient the scan was unreadable due to hepatomegaly : 
viii) Miscellaneous 
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Forty consecutive scans were reported on without knowledge of any 
clinical detail. These patients were chosen and the scans were superivised by 
a colleague. 
The cases in this study are tabulated in Table 3 . 6 
Tobie 3.6 
Diagnostic Asseument of the Pancreatic Scans of 40 
Consecutive Unselected Patients 
Normal: 
Abnormal: 
Carcinoma of the pancreas 
Acute and chronic panc:reatitis 
Diabetes mellitus 


















Scans were designated either normal or abnormal. Because the experience 
of the first 160 patients had indicated the variety of pathology which could 
influence pancreatic 
75
Se - selenomethionine uptake, no attempt was made 
to state a definitive diagnosis. Instead a list of the diagnostic possibilities 
was stated in order of probability. 
Result: (Table 3. 6 ). 
There were 3 errors in diagnosis. One patient whose scan was believed 





pancreas. This region had been passed over as normaa physiological thinning 
on the initial reading but a review of the scan showed a circumscribed filling 
defect. This is clearly a fault of interpretation. 
In 2 patients the scan was thoughtto show a generalized diminution 
of uptake. In neither of these patients was there biochemical or clinical ' · 
evidence of pancreati'c disease. Both patients were over the cige'of ·65 years • 
• , I I 
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Part 6. Discussion 
.,\ 
1 1 4 
Since the introduction of 
75
se - selenomethionine there have been 
numerous reports describing various features of the normal and abnormal pan-
creatic scan. (Blau, 1964; Sodee, 1964; Beierwaltes, 1964; Haynie, 
Svoboda and Zuidema, 1964; Rodriguez - Antunez, 1964; Burke and 
Goldstein, 1964; Burdine and Haynie, 1965; Lahdevirta and Haikonen, 1965; 
b 
Diethelm and Haacke, 1965; Sodee, 19 ; Rodriguez - Antunez, Filson, 
Sullivan and Brown, 1966; Van Vaerenbergh, Van Vaerenbergh, Demeul-
enaere, Yvergneaux and Barbier, 1966; King, Sharpe, Grubb, Brock and 
Greenberg, 1966; Mizukami, 1966, Centi Colella and PiJorini, 1967; 
Brown, Sircus, Smith, Donaldson, Dymock, Falconer and Small, 1968). 
Howev•r, there has been no systematic attempt by any author/s to document 
fully the variations of normality and the patterns of abnormality. 
A variation in the position and shape of the normal pancreas has been 
reported by Diethelm and Haacke (1965), Rodriguez -Antunez, Filson, 
Sullivan and Brown (1966), King, Sharpe, Grubb, Brock and Greenberg (1966), 
Centi Colella and Pigorini (1967) and Kaplan, Ben-Porath, Fink, Clayton 
and Jacobson (1966). The experience of this study has been similar, though 
a truly "horse - shoe" shaped pancreas (King, Sharpe, Grubb, Brock and 
Greenberg, 1966) has not been encountered amongst the normal scans. 
believe that such a shape is very uncommon, and that a mistaken interpretation 
of a "horse-shoe" shape may be made when considerable bowel uptake of 
the itotope occurs (Fig.3, 'I ) . De Nardo, Crowley, Pardoe and Weintraub 
(1967) claim to have demonstrated in dogs that the total duodenal mucosal 
uptake of selenomethionine is about half of that in the pancreas. The obser-
vations in human scans supports this though there is great variation in bowel 
uptake from patient to patient. The constancy of the extrapancreatic shadow 
posit,•n 
strongly suggests intramural uptake of the isotope in a relatively fixed pestie111 
of the bowel wall rather than the passage of secreted enzymes along the bowel 













and the constancy of its pesition in different timed scans in the same individual, 
is additional evidence in favour of intramural uptake. 
Attempts at the physical displacement of the liver edge by positioning 
the patient have not produced a convincing improvement in the quality of 
the scan and overlap persists (Diethelm and Haacke, 1965; Rodriguez-Antunez, 
Fil~n, Sullivan and Brown, 1966; Centi Colella and Pigorini, 1967). A 
lead shield placed over the liver after determining its position by an 
198 Aa 
colloidal gold scan (Sodee, 1964; Oiethelm and Haacke, 1965) has also been 
unsuccessful in improving the quality of the scan. Burke and Goldstein (1964) 
tried unsuddessfully to block the hepatic uptake of selenomethionine by feeding 
their patients supplementary methionine in the diet for a few days prior to the 
pancreatic scan. 
The most promising development in separating hepatic from pancreatic 
uptake comes from Kaplan, Ben-Porath, Fink, Clayton and Jacobson (1966) 
who used a dual - channel scanning machine. This technique permits either 
electronic subtraction of the liver from the print - out or simultaneous display 
of liver and pancreas in separate colours. A similar subtraction technique 
has also been described by Eaton, Potsaid, Lo and Beaulieu (1967). The 
presence of some overlap however does not necessarily invalidate the scan 
although it tends to limit its diagnostic value if the pancreas is abnormal. It 
should always be possjble to discem an area of reinforcement in the hepatic 
shadow which conforms to the contour of the pancreas. Complete absence of 
this reinforcement in the experience of this study has invariably been associated 
with significant disease of the pancreas. 
The best documented abnormality of the pancreatic scan is carcinoma 
(Blau, 1964; Sodee, 1964; Rodriguez-Antunez, 1964; Haynie, Svoboda and 
Zuidema, 1964; Burke and Goldstein, 1964; Burdine and Haynie, 1965; 
lahdevirta and Haikonen, 1965; Van Vaerenburgh, Van Vaerenburgh, 












De·meu'lenaere, Yvergneaux and Barbier, 1966; Rodriguez -Antunez, Filson, 
Sullivan and Brown, 1966; Kakehi, Tateno, Uchiyama and Tsuchiya, 1967; 
Kaplan, Ben-Porath, Fink, Clayton and Jacobson, 1966; Tabern, Kearney 
and Dolbow, 1965). Under ideal conditions it is possible for a 2 to 3 cm. 
diameter tumour to be detected. However, as stressed by laconi, Melf;, 
Cataliotti and Semilia (1965) this probably depends in part on the position of 
the growth in the pancreas. Small localised lesions towards the edge of the 
gland being be•r detected than if situated in the middle of the parenchymo, 
of the head for examp.le. 
Rodriguez-Antunez (1964) and Kakehi, Tateno, Uchiyama and Tsuchiya 
(1967) have suggested the following signs as indicative of a pancreatic tumour 
on the scon:-
a) a localized filling defect; 
b) displacement of pancreatic tissue outside the normal outline of the 
pancreas; 
c) distortion ofad narrowing of any segment of the organ; 
d) lack of visualization of all or part of the gland; 
e) a filling defect in the liver scan. 
However it is apparent from this study that all these features can be caused by 
a variety of pancreatic or extrapancreatic pathology other than neoplasia. Of 
the features Listed, the abnormality most suggestive of on intrinsic neoplasm 
is a localised filling defect within the substance of the pancreas parenchymo 
especially if a has a concave rounded edge (Fig.3 .11 ). Attention to this 
particular detail should ha.ve avoided the error of interpretation made in the 
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blind study reported on page. 111 Involvement of the pancreas by secondary 
carcinoma may result in displacement of the tissue outside the normal contour 
though this is admittedly a very uncommon occurrence. However, the presence 
of a pseudopancreatic cyst may show as an area of more extensive activity 
related to the body and tail of the pancreas (Fig. 3•11 ). Distortion and 
Fig.3.23:(Patient 5 ): Photoscan of o 198Au colloid gold liver scan 
showing a pseudofilling defect between right and left lobes 
of the liver. This patient had a carcinoma of the head of 
the pancreas with common bi le-duct obstruction. There were 
no metastases detected in this position at laparotomy. 
Page HS. 
narrowing of any segment of the organ may occur with any mass adjacent to 
the pancreas (Fig.3.21 ). Lack of visualisation of the entire or part of the 
gland may occur with a variety of conditions such as acute or chronic pancrea-
titis, cholelithiasis, diabetes mellitus and postgastrectomy, gastroenterostomy 
or vagotomy: This is certainly the least specific of the [!carcinoma signs" 
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and should be interpreted with caution. In complete common bile-duct 
obstruction it is common to find a filling defect on the hepatic scan between the 
right and left lobes of the liver (Fig.3,23 ). This occurs irrespective of the 
cause of the obstruction and is believed to be a consequence of the obstruction 
itself. The defect does not necessarily represent tumour invasion of the liver 
substance. It was present to a greater or lesser degree in all the patients with 
carcinoma of the common bile-duct whether or not the carcinoma was actually 
involving the liver substance. On the basis of this study it would seem as if the 
two changes most suggestive of carcinoma are -
i) a localised circular filling defect (Fig.3, II ) or 
ii) distortion and disruption of the normal pancreatic contour, possibly 
associated with a filling defect as well, such as is illustrated in fig.3 .13 ). 
However, that even these signs cannot be interpreted dogmatically is clear 
from the experience of the scan depicted in Fig.3,2.'+ ). This patient was 
submitted to an elective re-exploration of the pancreas on the basis of this scan 
as it seemed almost certain that he was harbouring a carcinoma. This impression 
was strengthened by the history or relapsing pancreatiti:S.. The changes were 
due however to a pancreatic infarct without a trace of neoplastic tissue on 
microscopic examination of the resected specimen. 
The problem of enhanced uptake by normal or neoplastic tissue is much 
more difficult to assess. In the case of the poorly differentiated oC - cell 
islet tumour presented (Fig.3.llt•), the gland was the seat of chronic pancrea-





Fig.3.24: (Patient JI ): Photoscan depicting a filling defect in the 
body and tail of the pancreas. This was due to an infarcted 
necrotic area of pancreatic parenchyma associated with 
relapsing pancreatitis. Page I I 8 . 
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The very considerable isotope concentration in the tail in an area largely 
occupied by the infiltrating functioning carcinoma suggested a situation 
analogous to selenomethionine. concentration by functioning parathyroid aden-
omas (Potchen, Wilson and Dealy , 1965). A follow-up scan in this patient 
4 months after a distal pancreatectomy showed disappearance of the active area 
(Fig.3 ,lltll) . At this time the basal acid output had decreased from 20mEcy 
hour pre-operatively to 5 mEcyhour after the operation. Burke, Finer and 
Sandlow (1964) have reported a localized functioning non - ft islet cell tumour 
nodule associated with the Zollinger- Ellison Syndrome and hypercalcaemia in 
which the pancreatic scan showed a c; filling defect in the body of the pancreas. 
On the other hand the patient reported in this study had a diffuse lesion with 
no recognisable tumour nodules. Brown, Sircus, Smith, Donaldson, Dymock, 
Falconer and Smal I (1968) report the case of a pancreatic tumour associated 
with gastric hypersecretion and potassium - losing watery diarrhoea in which 
the pancreatic scan showed "an enormously increased uptake throughout the 
whole pancreatic mass". There may be local metabolic and vascular factors 
responsible for the difference in scanning appearance. For example, in advance 
lymphosarcomo there may be a high uptake of 
75
Se - selenomethionine but 
not in the early lesion (Herrera, Gonzolez, Schwartz, Diggs and Belsky, 
1965). The question of selenomethionine concentration by functioning tumour 
tissue must await further experience with these rare tumours . Analyses by 
Gregory and Tracy {1966) of human gastrin, hove shown that it contains methionine. 
Because there is no methionine in insulin, an insulinoma would be expected to 
manifest as o filling defect on the scan . This supposition is supported by th4 
case presented by Haynie, Svoboda and Zuidema (1964) and that reported by 
Brown, Sircus, Smith, Donaldson, Dymock, Falconer and Small (1968) . 
It would appear that any condition preventing the normal synthesis of 
digestive enzymes by the pancreas is likely to manifest as diminished or absent 
uptake of 
75se - selenomethionine on the scan. Acute or chronic poncreatitis 
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may produce such a picture· • . fn chronic 'pancreatitis w"ith clinfcal ev-idence 
of exocrine insufficiency, diminished or ab$ent uptake is the rule (Fig.3 ,ltJo> . 
This is also the experience of Sodee (1964), Burdine and Haynie (1965), 
Lohde virta and Haikonen {1965) and Centi Colella and Pigorini {1967). In 
acute pancreatitis uptake is impaired in part {usually the head and neck) or 
whole of the pancreas. However here clinical recovery may be associated 
with restoration of the pancreatic scan to normality (Fig. 3,106 ). In all of 
the patients in thi, study scanned more than 3 weeks after the ottock, the 
pancreas appeared normal. This obsesvation is paralleled by the results of 
function tests. logerlof {1939) and Dreiling and Janowitz (1962) observed 
a diminution of enzyme secretion for o variable period after cm attack of acute 
poncreatitis. The volume and bicarbonate output recovers much more rapidly 
than enzyme output and may be normal 4 days after an acute attack {Dreiling 
and Janowitz, 1962) . These findings, together with the sc:an observations 
suggest that recovery of fu 11 acinar function after an attack of acute pancrea-
titis is slower them the recovery of duct function. 
The great majority of scans performed on patients with pseudocysts of 
the pancreas have been reported as showing areas of diminished uptake (Beierwaltes, 
1964; Waynie, Svoboda and Zujdema, 1964; Tabem, Kearney and Dolbow, 
1965; Van Vaerenburgh, Van Vaerenburgh, Demeulenoere, Yvergneaux 
and Barbier, 1966; Centi Colella and Pigorini, 196n. It is not possible to 
ascertain from the literature how many of these reports have ·been confirmed 
at laporotomy. By contrast in the cases of this study the pancreatic pseudo-
cyst is seen as an area of increased activity overlying the body and tail of the 
pancreas (Fig .J.11 ) . This apparent discrepancy almost certainly depends on 
whether or not the pseudocyst communicates with the pancreatic duct system. 
If the pseudocyst represents a "sympathetic" effusion in the lesser soc then com-
pression of the pancreas anteriorly by the pseudocyst would produce a filling 
defect on the scan. However communication of the pancreatic duct system 
-
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with the cavity of the lesser sac will result in the leakage of 75se - seleno-
methionine labelled enzymes into the pseudocyst with the appearances on 
the scan described above . The case report by Kaiser, Roth and Bockus (1955) 
demonstrates that at least in some patients with ps~udocyst, the enzyme 
(amylase, lipase) content of the pseudocyst fluid may parallel that found in the 
pancreatic duct . 
The pancreatic uptake of isotope is frequently diminished in patients 
with diabetes mellitus~ · This observation agrees with the experience of Sodee 1 
(196$) and of Lahdevirta (1967) . The latter author related the secret in 
response to the quality of the scan in 27 hospitalized diabetic :patients . Although 
he was measuring duct (that is, response to secretin) rather than acinar ' function 
he found that in 8 of 12 insulin dependant diabetics there was no pancreatic 
uptake on the scan. He 'stated that in general 11 the lowered pancreatic uptake 
corresponds fairly well to the pathological result in the secretin test" . · There 
have been several studies reporting decreased volume and bicarbonate and 
enzyme secretion by the pancreas in patients with diabetes mellitus (Jones, 
., Btc~,,. 
Castle and Mulholland, 1925; Lagerlof, 1939; Pollard ...-. Miller~ 1943; 
Vacca, Henke and Knight, 1964; Chey, Say and Shuman, 1963; Bock, Bank, 
Marks and Jackson, 1967). Although this observation does not appear to be 
of much clinical significance it is important to realise that marginally decr-
eased pancreatic function and a poor scan in acfiabetic subject does not 
necessarily imply underlying pancreatitis or carcinoma but may be an association 
of the diabetic condition per se. 
The finding of 4 cases of 11silent11 pancreatitis in the group of patients , 
with cholelithiasis parallels the experience of Sodee (1965) and Brown, Sircus, 
Smith, Donaldson, Dymock, Falconer anti Small (1968) who also noticed that 
some patients with cholelithiasis concentrate the isotope poorly in the pancreas . 
This observation is presumeably associated with the presence of some structural 
.. 
-
1 2 3 : 
change in the parenchyma .because ·3 of the 4 patients in this study, at 
operation were found to have induration of the pancreas. The relationship 
between these conditions however remains obscure. 
The reduced isotope uptake in at least 4 of the 11 patients who have 
undergone gastric surgery may indicate the importance of on intact upper 
gastro-intestinal tract for optimum pancreatic function. Gastroenterostomy 
or Polya gastrectomy will bypass the duodenal loop and exclude the most 
important physiological mediators of pancreatic enzyme release. Partial 
gastrectomy which almost invariably sacrifices the gastric antrum may be 
associated with the loss of the pancreatic enzyme and volume response to gastric w 
disterlion ($hite, Hoyama and Magee, 1960; Harper, Blair and Scratcherd, 
1963). The vagus has been demonstrated to have a permissive action on pan-
creatic enzyme and fluid secretion (Brown, Harper and Scratcherd, 1967). 
Vagotomy will tend to minimize the pancreatic response to humoral mediators 
of secretion (Pfeffer, StepheNOn and Hinton, 1952). 
The failure of isotope uptake in the one patient with fibrocystic di.ose 
was adequately accounted for at autopsy with the demonstration of extensive 
fibro - fatty replacement of the pancreatic parenchyma. This very limited 
experience paralleled that of Quinlan, Way and Joske (1967) who record 
the case of a 28 year old man with small bowel obstruction due to "meconium 
ileus equivalent". The patient had no upklke of 
75
Se - selenomethionine 
on pancreatic scanning. The parencymal atrophy and fibro - fatty replace-
ment in the case reported in this study is said by Bodian (1952) to occur 
characteristically in older children suffering from this disease. 
Absence of uptake in the patient with extensive primary omyloidosis 
was associated with extensive pancreatic parenchymal involvement by amyloid 
at autopsy. In spite of the absence of a family history the extensive neuro-
' 
·- -- - - - -"' 
logical and gastrointestinal involvement by amyloid in this patient was very 
similar in distribution to that occurring in the syndrome of familial amyloidosis 
described by Andrade (1952). 
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The poor pancreatic uptake in 2 out of 3 patients with a positive Kveim 
test and paroid enlargement cannot be accounted for ~n the· data available. As 
yet none of these patients have had formal pancreatic function tests. . Clinical 
symptoms due to pancreatic disease in patients with sarcoidosis would appear to be 
a rare occurrence and case.reports of this association a·re few (Ekel:nd, 1946; 
Curran and Curran, 1950). 
There have been few attempts to correlate the ;esults of the conventional 
pancreatic function test ·with the changes seen on sccin~ing. The study by Lahde-
virta (1967) relating the pancreatic secretin response to the uptake of 
75
se - sel-
enornethionine as seen on scanning in diabetic patients suggested a general con-
cordance of results. Brown, Circus, Smith, Donaldson, Dymock, Falconer and 
Small (1968) studied 20 patients by both pancreatic scanning and by the pancreatic 
function test of Marks and Tompsett (1958) utilizing secretin and pancreozymin 
injections. Twelve scans were normal, and in these patients c::.onventional tests 
were normal in 9 and abnormal in 3. It seems probable from the clinical details 
that in at least 2 of the 3 patients the pancreas was structurally normal. Eight 
scans were abnormal and in 7 of these patients the conven.tional tests were also 
abnormal. These authors concluded that there was "a notable degree of agreement 
between the two tec::hn i ques n • 
In assessing the diagnostic:: accuracy of scan reporting, three mistakes were 
made in 40 consecutive patients scanned. The scan was viewed without having 
seen the patient and without any knowledge of the clinical details. This repre-
sents an accuracy of over 90% in answer to the question "Is this patient's pancreas 
normal or abnormal ?" As there is no other report in the literature of an assessment 
of scan reporting under conditions as stringent as this it is impossible to compare 
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this series with any other. In this writer's experience bias resulting from prev-
ious examination of the patient or the knowledge of clinical detail, or an earlier 
viewing of the scan may influence any subsequent assessment. It is felt that in 
general the most useful assessment of the pancreatic scan would come from first 
viewing the scan without any knowledge of the patient and then with full details 
of the patient's clinical status. This should permit more accurate assessment of 
borderline cases and permit a re-assessment in patients in whom signs may have 
been misinterpreted. The overall impression has been gained from this study 
that in patients in whom the pancreatic 
75
Se - selenomethionine uptake has been 
designated as "very good 0 or "excellent" throughout the organ, the likelihood 
of occult underlying pancreatic disease is very remote. This is similar to the ., 
experience of Sodee (1965t). 
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Part 7. Conclusions 
In general a wide variety of disease processes involving the exocrine 
pancreas are likely to diminish uptake of 
75se - selenomethionine by the pancreas. 
From the experience of this study the majority of abdominal scans do not offer a 
definitive pathological diagnosis on the features of the scan alone. In these 
cases ultimate interpretation of the scan, as with most ancillary investigations 
must be related to the clinical picture and the results of other investigations. 
The two most distinctive abnormalities seen on scanning were those 
due to pseudopancreatic cyst (Fig. 3. 11 ) and extrinsic displacements of the 
pancreas (Fig.3.11 ,, .3.22.. ). It should be possible on the basis of these 
distinctive patterns to make a diagnosis from the appearance of the scan alone 
i.e. whether the abnormal tty is due to a pseudopancreatic cyst or extrinsic dis-
placement of the pancreas. The signs most suggeative of carcinoma of the pancreas 
are a localised filling defect within the substance of the gland or a filling defect 
with disruption of the normal pancreatic morphology (Fig.3.13 ). In a patient 
with acute pancreatitis and generalised failure of 
75
Se - selenomethionine 
uptake by the pancreas, the presence of an underlying pancreatic carcinoma 
cannot be excluded by scanning. 
In general, the finding of an unequivocally normal scan can be taken 
as strong evidence against there being significant pancreatic disease present. 
I 
CHAPTER 4 
AN EVALUATION OF 
75s. - L - SELENOCYSTINE AND 
75s. Dlmeso - SELENOCYSTINE AS PANCREATIC 
SCANNING AGENTS. 
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- ·- ... The're- is no information concerning the suitability of 75se - seleno-
cystine as a scanning agent and a pancity of information about its meta-
bolism. 
Considering the similarities in the metabolism of metli-onine and 
selenomethionine, it was felt on theoretical grounds at least that the 
metabolism of selenocystine would parallel that of cystine. 





Se-selenoc:ystine in rats, Anghileri and Marques_ (1965) reported 
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that the selenoamino acids showed o similar pattern of incorporation with 
comparable pancreatic specific activity at 8 hours. This finding is in keeping 
with Blau's (1964) observation in dogs in which he found comparable pan-
• • • f 14~ L h" • and 35 S L • creahc mcorporahon o .. - - met aorune - - cystane at one 
hour (Table 3. 1. ). Therefore it was felt that 
75
Se - selenocystine 
could possibly represent an alternative agent to 
75
Se - selenomethionine 
for pancreatic scanning. 
This study was undertaken primarily to assess the value of 
75
Se -
selenocystine as a pancreatic scanning agent. Both the DLmeso-and L -
configurations of 
75
Se ulenocystine are compared t.o., 
75
Se - L - seleno-
methionine in the rabbit and in man. Initially, Dlmeso-selenocystine was 
the only form of the radioactive compound available. This meant that the 
molecule was partly in th! unnatural 0- configuration and as a result the 
tiS$Ue uptake and metabolism would probably differ ft'Offl the natural 
L -selenocystine. A number of experiments were repeated for comparbon 
when 
75s. - L - selenocystine became available. 
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Part 1 • Potential Hazards in the Use of 75Se - Selenocystine 
' 
Radiation Dosimetry 
For the purpose of the dosimetry calculation it was assumed that the 
biological behaviour of selenoeystine would parallel that of cystine. This 
was shown b be correct in animal studies in that approximately 50% of 
the iniected activity was excreted within the fiqt 24 houl'I (Table 4.12.). 
In additon it was demonstrated that with the exception of the pancreatic 
activity, the di,tribution of activ'y in two rabbits seven days after an 
• • • • . f. 
75Se L I hi • nd. 75Se L intravenous an1ectaon o - - se enomet onane o - -
selenocystine (30rCi /Kgm. body weight of each) respectively, was 
comparable. However, beccause of the initially high excretion, whole 
body radiation from this compound would almost certainly be less. 
The radiation ~ge calculated on the basis of 4tA Ci/Kgm. for 
selenocystine is comparable to that of selenomethionine at 3t"Ci/Kgm., 
thus introducing a safety factor. This is contained in Appendix 2. On 
the basis .of-these calculotions permission was granted for the use of 
75
Se - selenocystine in humans at a dose of 3fACi/Kgm. body weight. 
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Toxicity of Selenocystine 
Klug, M.oxon, Petersen and Painter (1953) calculated that the 
LD50 of D1 L., DL or meso-selenocystine in rats injected intraperitoneolly 
le~tc.cl was 4.0 (10.2) mgs. Se/Kgm. body weight. E,tt,ep&letell to man 
(70 Kgm.) this would represent 2,500 to 3,000 times the quantity of sel-
enocystine administered in these studies. 
Cystine if administered parenterally may present problems through 
crystallization in the urinary tract. This however is a dose related phenom-
enon and is unlikely to be a, problem with the quantities used in ,these studies. 
For example, the available 
75
Se - selenocystine (Amersham) has a specific 
activity of 177 ~cVmN. A 3 to 4 t4 CVKgm dose to an adult would 
contain 180 to 240 /tA ims. of selenocystine. The normal excretion of 
cystine is 40 to 80 mg. per day (Harris, Mittwoch, Robson and Warren, 
1955). 
, 
In order to ensure stability selenocystine compounds have to be 
dissolved in O. 1 N hydrochloric acid. This injection, though administered 
rapidly proved painful to the patient and was usually aaociated with 
phlebitis at the site of injection. 
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Part 2. Material and Methods 
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75
se - Selenocystine Compounds 
The compounds used were:-
i) 
75
Se OLmeso - selenocystine • This was supplied as 1 .09 mCi dissolved 
in 170 rngs. O.IN hydrochloric acid. The specific activity was 177 m Ci/ 
mM and the selenocystine content 2 mgs. 
In the human studies the volume was made up to give a final concen-
tration of 1 mCi/ml. in O. IN hydrochloric acid. This concentration 
permitted small volume injections using a finely graduoted one millilitre 
syringe. 
In the animal studies a separate batch of the same isotope was used 
with the same initial concentration and specific activity. This was done 
both for hygienic reasons and to check the consistoncy of behoviour of 
different batches of the isotope. The initial volume was diluted to ten 
millilitres permitting more accurate estimation of the lower dose require-
ments of the rabbits. 
ii) 
75
Se - L - selenocystine. This compound was supplied as 2 mgs. of 
selenocystine dissolved in 2. 14 rngs. of IN hydrochloric acid and having 
2.0 m Ci total activity. The specific activity was 332 m Ci/mM. This 
was diluted tenfold first with sterile distilled water to give a final acid 
concentration of O. IN. The solution was made up to 2 ml. with O. IN 
hydrochloric acid, and then divided into two one millilitre (1 m Ci) portions 
in separate sterile dari<-glass containers. In the human studies the compound 
was used in this concentration ( 1 m Ci/ ml. ) • For the rabbit studies it 
wirh 
was further diluted to a concentration of lOOrCi/ml.10.IN hydrochloric 
acid. 
. - . . 'Both compounds were synthesized and a,pplied by the Radio-
chemical Centre, Amersham, Buckinghamshire, England, both sulphur 





Se - selenocystine. * 
;,I 
* Personal communication: Dr.J.Ogle. Head of the Inorganic 
Chemistry Department, The Radiochemical Centre, Amersham. 
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A. Animal Experimel\ts. 
i) Whole Body Counting of Rabbits 
Whole body retention of intravenously iniected 
75
se - seleno-
75 75 • methionine, Se - Olmeso and Se -L - selenocystme was followed 
in six young (l! to 2! Kgm.) New Zealand and Dutch rabbib (two rabbits 
for each compound) over one week: Each rabbit received 50 to 60r Ci 
of the 
75
Se - selenoamino acid via an ear vein. The whole body count 
immediately after the isotope iniection was taken as 100% retention. 
The rabbits were placed in a perspex box of internal dimensions 
34 cm. long X l4 cm. wide X 20 cm. deep with ventilation grills at 
either end. The box was placed with its centre 50 cm. from the face of 
the whole-body scintillation counter. This consisted of a 12.5 cm. diam-
eter X 10 cm. thick thaMium-octivated sodium iodide (Na I (Tl) ) crystal 
mounted in a 5 cm. thick shield of aged lead. A single-channel pulse 
height analyser was used to ..-ct counts in an energy band 100 to 400 KeV 
(corresponding to the 270 and 280 KeV gamma emission energies of 
75
Se). 
Two counts of 100 second duration were taken, the perspex box 
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being rotated through 180° between the two so that the rabbit was counted 
from both right and left-hand sides. A snaalf bottle containing approximately 
10 tA Ci 75Se was counted as a standard each time so that correction cou Id 
be made for radioactive decay and for any variations in the efficiency of 
the counter. 
The daily counts were corrected for background and radioactive 
decay was expressed as a percentage of an initial value taken 1 to 2 hours 
after the injection of the radioactive dose. 
ii) Scanning of Rabbits 
The six rabbits used for whole-body counting were scanned 30 
minutes and 5 hours ofter the isotope injection. 
The scans were performed with the Picker Magaa - Scanner V 
{Picker X-Ray Corporation, New York) on similar settings used for the 
75s. - selenomethionine human scans (Chapter 3). 
A Nfine-focus" collimator of nominal focal length 7 .5 cm. was 
used and o scanning speed of 24 cm./min. The rabbit was anaesthetised 
by an intravenous injection with Nembutal {pentobarbital) {28 mgs./Kgm. 
body weight) followed by open-mask ether anaesthesia. Where necessary 
and was held in position by straps J>CIISN round ol I four legs and fastened 
to the scanning couch and by a band of thin gauze across the c;abdomen. 
iii)a. Organ Distribution of lniected Isotope 
In this study the tissue distribution of 
75
Se - selenomethionine was 
compared to that of 
75
se - L - selenocystine. Three young Dutch rabbits 
(li to 2 Kgm.) were used. One was iniected with 75Se - selenomethionine 
and two with 
75
Se - L - selenocystine (30fACVKgm.). · 
Following the injection of selenoamino acid the rabbits were anaes-
thetised with Ne111butal (28 mgs./Kgm.) and heparinised by the intravenous 
iniection of 3000 u of heparin sulphate. After Immobilisation of the rabbit 
on a dissecting table, the external carotid artery was cannulated with a 
polythene catheter which passed into a flask strapped below the head of the 
rabbit. The catheter was filled with saline and the lumen occluded by an 
artery clip. 
Twenty minutes after the isotope injection the clip was released and 
the animal gradually exsanguinated under anaesthesia. The average time 
for exsanguination was always about 35 to 45 minutes. The time taken from 
iniection of the isotope to death of the rabbit averaged 60 ± 10 minutes 
in all animals. 
The liver, pancreas, stomach, small bowel, kidneys, spleen,gonads 
and heart were then rlllfflOved washed under a tap and dried with gauze swabs. 
The bowel was opened longitudinally and the mucoeal surface washed free of 
food particles and debris. The organs were weighed and secured in disposable 
pmstic Petri dishes. 
iii)b. Countir:lg of Rabbit Organs 
Counting was performed with the same scintillatiCXJ crystal as was 
used for whole-body counting, but pointed vertically downwards. The 
distance from ·the crystal surface to the base of the Petri dish placed below 
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it was 10 cm. except in the case of the liver when a 50 cm. distance was used 
because of the much greater radioactivity in this organ. 
Two ltandords, equal to 1% and 10% respectively of the dose given 
to the rabbit, were prepared (by volume) in small sealed bottles which were 
placed inside Petri dishes and' counted under the same geometrical conditions 
as the rabbit organs; the la.tter standard was used only for comparison with 
the liver sampl~ All samples were counted for times long enough to ensure 
that the error due to counting statistics was not greater than 1%. 
8. Human Studies 
i) Human Scans 
The human scans were performed under similar conditions and with 
similar machine setting1 to thole described for 
75s. - selenomethionine 
(Chapter 3) . Scans were performed 1 hour and 5 hours ofter the iniection 
~ . I ~ of Se - Dlmelo - selenocystane and at 1 hour and " days after Se - L -
selenocystin•. 
Two patients were infected with 
75s. - Dt..m.so - selenocystine and 
one with 
75s. - L - selenocystine- (3fA Ci/Kgm. ). All three patients wen, 
volunteen to whom the purpote and potential hazards of the procedure had 
been fully di1CU11ed . In none of the three wa there any clinical indication 
of pancreatic di ..... 
ii) Whole-Body Counting 
Whole body retention of 
75s. - L - selenocystine was studied in 
the one patient. Readings were made daily for 5 days and then every 
second or third day for 28 days . The patient aat in ca chair facing the 
scintillation counter at a 100 cm. from the crystal surface . The crystal 
was directed Just below the level of the "1f)histemum. Details of the 
whole-1,ody scintillation counter specifications and settings are identical 
to thole wed for whole-body counting of the rabbits . 
• 
t 4 1 
Part 3. Results 
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Fi .4.1: 
a) Animal Experiments 
i) Whole-&dy Isotope Retention 
The whole-body retention of the 
75
Se - selenoamino acids over 
7 days is plotted in Fig. 4 . l 
Both forms of selenocystine are rapidly excreted. · Table 4 . I 
depicts the isotope retention at 24 hours. 
Table 4.1 
1 4 3 
Rabbit No. 
75se - Selenoamino Acid Retention at 24 hours (%) 
1 75se - L - Selenomethionine 92 
2 II II II 86 (mean= 89) 
3 75se - Dlmeso -Selenocystine 45 
4 ti II II 35 (mean= 40) 
5 75Se - L - Selenocystine 64 
6 II II II 53 (mean= 59) 
Retention of L - selenocystine is greater than that of the Dlmeso -
form but both forms of selenocystine are excreted in much greater quantity 
than selenomethionine in the first 24 hours. 
ii) Abdominal Scans 
The scans of only one rabbit of each pair will be presented OIi the 
features to be described were repaduced on each occasion for each agent used. 
• 
Fig.4.2(a): 
75Se - DLmeso-S.1• ,stine 
Thirty minute scan. 
Fig..4.2( ): 
7Sr_ L I • . ..- - -tee IOOIM 
Thirty inut• scan. 
75
Se - L - Selenomethionine (Rabbits No's. 1 and 2) 
a) Thirty Minute Scan (Fig .4,'ZI). 
The early distribution of isotope showed major areas of activity in 
the liver, kidneys and bladder. A prominent area of activity medial to the 
right kidney was interpreted m being pancreatic uptake, possibly reinforced 
by adjacent, small-bowel and stomach. The right kidney impression has 
been reinfor~ by the right lobe of the liver accounting for the apparent 
density difference between right and left kidneys. 
b) Five Hour Scan (Fig.4.1ij. 
Uptake in all viscera appean to have increased. This is particularly 
notable in the kidneys and bladder, the latter organ also being larger in 
size. 
75se - Dlmeso - Selenoc)'ltine (Rabbits No's. 3 and 4 ). 
a) Thirty Minute Scan (Fig.4.l.a). 
The early distribution of i~tope shows a striking concentration of 
activity in the liver, kidneys and bladder. The prom~nence of renal and 
bladder activity is accentuated by the lack of background activity in the 
rest of the abdomen. 
b) Five Hour Scan (Fig.4.3.). 
This scan shows a considerable reduction of renal activity with an 




Se - Dl - meso - seJet cy,tine 
Five hour scan. 
Fig .4 . 3(b): 
75
Se - l - s.eleno thionine 
Five hour 1can. 
1 4 6 
Fig .4.4(a): ig.4 .4(b): 
75 
cysti 75 - L - sel cysti 
Se - L-sef 
Thirty inute Five= our sc n 
(The are inclu in both scans). 
75se - L - Selenocystine (Rabbits No's. 5 and 6). 
a) Thirty Minute Scan (Fig.4, 4A). 
This scan shows prominent uptake in the liver, kidneys, bladder, 
bowel and pancreas. The liver and renal uptake is particularly prominent. 
b) Five Hour Scan (Fig.4.t,.I:,). 
There has been an enormous increase in the activity and size of the 
bladder. Though the liver activity has increased the general background 
(small bowel and pancreas) activity has decreased. 
iii) Organ Distribution of Injected Isotope 
The organ distribution of injected isotope at one hour is given in 
Table 4.i • 
The pancreatic specific activity is greater than the hepatic in the 
case of 
75
Se - selenomethionine. The reverse is true for 
75
Se - seleno-
cystine and ·the total hepatic activity for 
75
Se - selenocystine is approx-
imately twice as great as that of 
75
Se - selenomethionine. Uptake in the 
h nd 11 bo I · r 75s I h" • ho · · stomac a sma we 1s greater ,or e - se enomet 1onine t n 1t 1s 
r 755 I • ror e - se enocyshne. 
75 Renal activity is approximately twice as great for Se - seleno-





































































































































































































































- D&.m.o - Selenocysti • 
Hu bdomi I scan COIMlenced mi <after 
inj ction of the isotope. The black line represents t e 
ce JIIC!lricings of the costal mar9in. 
b) Human Studies 
The 
75
se - Dlmeso and L - Selenocystine Pancreatic Scan 
The features of the pancreatic $cans were similar for both compounds 
and they wi 11 be described togethea 
Patient No.1. 
75
Se - Duneso - Selenocystine 
Fig. 4. ~ shows the scan performed 40 minutes after the isotope 
injection. There is a marked renogram effect which was confirmed by the 
posterior scan {fig.4.~ ) performed immediately afterwards. The position 
of the kidne)II is wel I demonstrated. 
In Fig. 4.1 a scan performed 5 houn after the injection of isotope 
shows a reduction in the renal density and of the reinforced density passing 
from the upper pole of the left kidney to the mid-portion of the right kidney. 
This was taken to represent pancreatic uptake. 
Patient No. 2. 
75
Se - L ·- Selenocystine 
1 5 1 ~ 
Fig. 4. 8 also shows a prominent renogram effect~ However 
pancreatic uptake is more easily discemable in this scan as a density passing 
obliquely down from the upper pole of the left kidney towards the mid-portion 
of the right kidney. 
A scan perfonnecl 5 days later (Fig.4.1 ) shows a generalised reduc-
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75 
Fi .4. 7: $e - Olmeso - lenoc:yshne: 
rfo the 10t118 p.ati t 
Page ISi • 
Five hours 
in fig.4.5. 
fig.4. 75 Se - l - selenocystine: 
scan comr'nenced 30 minut 
injection. Page IS I • 
15 4 
' ' 
Human a-hdo inol 
ofter the isotope 
1 5 5 
Fig .4 .9: 
75 · 
Se - L - seJenoc)'$tine: Scon performed ot 
5 doys on th $Om patient di in fig .4 .8 . 
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Whole-Body Retention of 
75
Se - L - Selenocystine 
75 Whole-body counting of the patient injected with Se-L - seleno-
cystine showed an initial rapid reduction of activity with 65% retention 
after 24 hours and a half-life of 13 days (Fig.4. 10 ). 
157 
1 5 8 
Part 4. Interpretation of Results 
1 5 9 
Animal Studies 
i) Whole-Body Isotope Retention 
There is a striking reduction in whole body activity by 24 hours in 
the rabbits injected with the 
75
Se - selenocystine compounds. This implies 
the excretion of approximately 50% of injected 
75
Se - selenocystine as 
compared to 10% of 
75
Se - selenomethionine within the first 24 hours 
after injection. 
It is noted that the mean retention of 
75Se .. L - selenocystine (59%) 
is greater than that of the 
75
Se - DLmeso - selenocystine (40%). This 
probably reflects the better tissue utilization of the naturally occurring 
form of the selenoomino acid. 
ii) Abdominal Scans 
In the 
75
Se - L - 1elenomethionine scans, the increased visceral 
uptake at 5 hours presumably reflects. the clearance of circulating isotope 
from the blood stream. The activity in the kidneys .and bladder indicates 
the loss of some of the original isotope through the urinary system. 
The 
75
Se - Olrneso - selenocystine scans, particularly when compared 
to 
75
Se - selenomethionine, suggest rapid renal clearance and generally 
poor tissue utilization of the injected isotope. 
The scans of 
75
se - L - selenocystine appear intennediate to those 
of the preceding two selenoomino acids:-
i) There is considerably more urinary tract activity in these rabbits 
than in those injected with 
75
Se - L - selenomethionine. This probably 
reflects a much greater urinary excretion of isotope; 
ii) There is generally less background activity in the 5 hour scan 
as compared to the 
75
Se - selenomethionine, reflecting less bowel utili-
zation of the 
75
Se - L - selenocystine. However background activity is 
higher with the l - form tban with the Dlmeso - form of selenocystine. 
This presumably reflects better tissue utilization of the naturally occurring 
form of the selenoamino acid. 
iii) Organ Distribution of Injected Isotope 
This study confirmed the impression of isotope distribution obtained 
from the scans. Besides the liver, uptake in the pancreas, small bowel and 
stomach is relatively high with 
75
Se - L - selenomethionine . With 
75
Se -
L - selenocystine renal activity is much more impressive and stomach, small 
bowel and pancreas uptake relatively low. 
1 6 0 
Human Studies 
The behaviour of 
75
se - selenocystine in humans was similar to 
that in rabbits i.e. a significant fraction of the injected dose is rapidly 
cleared by the kidney. This is associated with a strong renogram effect 
on the scan. In none of the three patients scanned was the pancreatic 
image particularly strong. 
This more rapid renal clearance of 
75
Se - L - selenocystine is. 
reflected in the half-life of 13 days as determined by whole -body counting. 
1 6 , 1 _ 
1 6 2 
Port 5. Discussion 
The behaviour of selenocystine in man is similar to that in rabbits 
and is characterised by the rapid renal clearance and excretion ol a signi-
ficant proportion of the intmvenously injected dose. The prominent reno-
gram effect would tend in man to hinder satisfactory interpretation of the 
pancreatic scan as in all three scans the tail of the pancreas overlapped 
the upper pole of the left kidney. As this anatomical relationship is a 
constant one, it could only add to the probllas of scan interpretation. 
It seems unlikely that the pancreatic image can ever be as satisfactory 
with selenocystine as it is with selenomethionine. If hepatic total and 
specific activity are greater than that of pancreas (assuming the rabbit 
results can be extrapolated to humans), then calibration of the scanning 
machine over a hot-spot in the liver would tend to minimize pancreatic 
activity and the pancreas would show up poorly on the scan. Furthermore 
any increase in 
75
Se - selenocystine dosage to improve the quality of the 
pancreatic scan (the radiation effect being offset by the moee rapid excre-
tion), would be associated with a concomitant increase in renal activity 
as well. 
The behaviour of systemically injected selenocystine appears to be 
similar to that of the parent amino-acid cystine. Blum (1904) noted that 
injection of cystine into the peripheral vein of dogs resulted in a large amount 
of cystine being excreted with the urine, with the formation of cystine 
crystals. Steams and Lewis (1930) confirmed these findings by injecting 
cystine into rabbits. 
The behaviour of the different configurations of selenocystine used 
in the experiments. described, confirms that this factor is of particular impor-












































































































































. , 16 5 
body retention studies and ,the pancreatic scans in the rabbits suggested that 
L .. selenocystine was better retained and presumably better utilized by a 
larger number of organs than was the Dlrneso-selenocystine. The larger 
renal excretion of the filtered Dlmeso - selenocystine would suggest that 
the configuration of selenocystine is also important for transport of the 
selenoomino acids by the renal tubule. This observation is consjdered 
to be valid os the trace quantities of selenocystine used in these experiments 
are unlikely to have flooded the absorptive capacity ~f the renal tubules. 
In a study comparing the fate of injected 
75
Se - selenomethionine 
and 
75
Se - selenocys.tine in rats, Anghileri and Marques (1965) reported 
that both selenoamino acids show a similor pattern of visceral incorporation. 
Throughout the 7 days of their study the activity primarily incorporated into 
the liver remained steady, but in other organs it decreased with the exception 
of the testes which showed a nconsiderable" increase throughout the course 
of the experiment (both for selenomethionine and for selenocystine). 
Observations of the tissue levels of the injected selenoamino acids in rabbits 
ot 7 days (Table 4.3 ) shows a fall in all organ activity as compared to 
the 1 hour level (Table 4.2.. ). The general difference in results as compared 
to the rat studies may well reflect a species difference in the metabolism of 
these compounds. However, the. rat tends to be coprophagic unless de.lib-
erately prevented. Anghileri and Marques do not mention measures to 
prevent coprophogy and in such studies this could be on important factor in 
the recycling of excreted isotope. 
16 6 , 
Part 6 . Conclusions 
Neither 
75
se - L - nor 
75
Se - Dlmeso - selenocystine offer any 
dv 
75s L I h· · · • a antage over e - - se enomet aomne as poncreotac scanning agents . 
Because of the additional problem of renal overlap they are much less 
satisfactory agents . 
From the whole-body retention studies and abdominal scans in rabbits 
it appeaB that tissue utilisation of the natural L - configuration of seleno-
cystine is greater than that of the Dlmeso - form. Because of the larger 
fraction of injected Dlmeso - selenocystine lost in the urine j.t i$ likely 
that renal tubular t~nsport is also influenced by the configuration of the 
compound . 
Selenocystine injected via a peripheral vein behaves in a similar 
fashion to cystine in that a relatively large proportion of the dose is rapidly 
cleared and excreted by the kidneys. 
f 6 7 
_/ 
CHAPTER 5 
ATTEMPTS TO POTENT IATE 
75
Se - SELENOMETHIONINE UPTAKE 
BY THE PANCREAS 
1 6 8 
16 9 
.The two maan c:idvan.tages · which are· likely"to .result" from .potentiat"ing 
pancreatic selenomethionine uptake would be to simplify the reading of the 
pancreatic scan and to increase its diagnostic accuracy. There have been three 
main approaches to this problem . Firstly there have been attempts to stimulate 
protein synthesis by the pancreas to increase amino - acid uptake. Secondly, 
increasing the pancreatic blood flow would present a larger fraction of the pulse 
injection of 
75
Se - selenomethionine to the pancreas for utilization . Thirdly, 
retarding the release of synthesized protein may potentiate the scan appearance . 
This last possibility implies the assumption that secretion of 
75
se - selenome-
thionine containing enzymes occurs before completion of the· scan and that this 
results in loss of activity in the pancreas. 
Attempts have been made to stimulate pancreatic protein synthesis and 
blood flow in order to enhance uptake of the radioactive label. Methods used 
include a high protein feed (Blau, 1964; Haynie, Svoboda and Zuidema, 1964; 
Burke and Goldstein, 1964; Diethelm and Haacke, 1965; Sodee, 1964; 
Rodriguez - Antunez, Filson, Sullivan and Brown, 1966; Van Vaerenburgh, 
Van Vaerenburgh, Demeulenaere, Yvergneaux and Barbier, 1966; King, 
Sharpe, Grubb, Brock and Greenberg, 1966; Centi Colella and Pigorini , 
1967; Laconi, Melfi , Cataliotti and Semilia, 1965); pancreozymin - secretin 
injections (Blau, 1964; Haynie, Svoboda and Zuidema, 1964; Beierwaltes, 
1964; Diethelm and Haacke, 1965) and amino - acid infusions (Tabem, Kearney 
and Dolbow, 1965) . None of these have proved successful . 
Likewise, attempts to delay the secretion of the formed enzymes by 
morphine or probanthine injections have not improved the quality of the pancrea-
tic scan (Rodriguez -Antunez, 1964; Diethelm and Haacke, 1965; Tabem, 
Kearney and Dolbow, 1965; Van Vaerenburgh, Von Vaerenburgh, Demeule-
naere, Yvergneaux and Barbier, 1966) . 
1 7 0 
In keeping with the experience of Burdine and Haynie (1965), Lahde-
virta and Haikonen (1965), Sodee (1965), Kaplan, Ben - Porath, Fink, 
Clayton a1'1d Jacobson (1966), Centi Colella and Pigorini (1967) and Kakehi, 
Tateno, Uchiyama and Tsuchiya (1967) special preparatory techniques were 
not used in tha majority of patients in the study reported in Chapter 3. However, 
the patients were encouraged to take as complete a diet as possible for the few 
days preceding the scan and where possible, a large breakfast on the morning 
of Hie scan. The impression was gained that in genera: the quantity of food 
consumed prior to scanning did not greatly influence the quality of the scan. 
This applied too to the first 15 patients of the series to whom a supplementary 
drink of protein concentrate of 20 to 40 gm. had been given 1 to 1! hours 
· h 75s I h" · · · · prior to t e e - se enomet 1on1ne m1ect1on. 
The search for an agent which could increase pancreatic 
75
Se - seleno-
methionine uptake and so improve the quality of the scan led to a review of the 
effects of the .1aturally occurring trypsin ,nhibitors on the pancreas. 
1 7 1 
Part 1. The Effects of the Naturally Occurring Trypsin 
lnhibiton on the Panc:reos 
1 7 2 · 
Since 1948 (Chernick, Lepkovsky and Chaikoff) it has been known 
that chickens fed on raw soybean meal develop large pancreases with an increased 
protease content. In 1960, Booth, Robbins, Ribelin and Deeds studied the 
heart, lungs, thyrpid, testes, spleen, liver, pancreas, kidney, adrenals and 
intestine of rats fed a control diet and one supplemented with raw soybean meal. 
Al I organs were found to be normal except the pancreases of animals fed raw 
soybean meal. In these the acinar cells were considerably hypertrophied and 
packed with z:ymogen content. This histological impression of acinar hyper-
trpphy was corroborated in chickens fed raw soybean meal by Saxena, Jensen, 
McGinnis and Lauber (1963). These observations received biochemical con-
fi rrnation in a study by Konijn and Guggenheim (1967) who demonstrated an 
increased ribonucleic acid (R.N.A.) content in the pancreas of ratl fed raw soy-
bean meal. The deoxyribonucleic acid (D.N.A.) content of the raw soybean 
fed animals was similar to that of controls but the D.N.A. concentration per 
gland was significantly leu, suggesting that the pancreatic enlargement was due 
to a true hypertrophy rather than a hyperplasia of the cells. The increased 
R.N.A. content of the pancreas in the raw soybean fed rats was in keeping with 
the greater protein synthesizing capacity of these pancreases • 
. 
In 1961, Har,es and Lymon implicated the trypsin inhibitor in raw 
soybean meal as a pancreatic stimulator resulting in the excessive formation of 
pancreatic enzymes with the subsequent loss of critical amounts of limiting 
amino - acids in the faeces. In this way they could explain the enlarged 
pancreas, poor growth and large faecal nitrogen excretion noted in rats or 
chickens fed on large supplements of raw soybean. This hypothesis was supported 
by the observation of Booth, Robbins, Ribelin and De Eds (1960) that the add-
ition of the 4 amino - acids, threonine, valine, methionine and tyrosine to a 
raw soybean diet, corrected the poor growth and reduced food efficiency but did 
not prevent pancreatic hypertrophy. In 1963, Rackis, Smith, Nash, . Robbins 
and Booth showed that the greatest inhibition of rat growth and enlargement of 
17 3 
the pancreas occurred with ,meal fractions possessing· very high trypsin"- -innibitor 
activi°ty~ Meal frac.tions ·possessing low trypsin inhibitor activity inhibited 
growth and caused pancreatic enlargement to a lesser degree. 
Jn studying the effects of the naturally occurring trypsin inhibitors on 
the mammalian pancreas Melmed and Bouchier (1968) demonstrated that a low 
dietary supplement of the purified trypsin inhibitors from a variety of sources 
(soybean, ovomucoid and bovine pancreas respectively} are powerful inducers 
of amylase synthesis (Table 5. I ) and therefore presumeobly of the other digest-
ive enzymes as well, in the rat pancreas . 
Lymon and Lepkovsky (1957) and Lyman, Wilcox and Monsen (1962) have 
shown that a single supplement of the purified trypsin inhibitor to the diet in rats 
is capable of stimulating an exaggerated secretion of digestive enzymes from the 
pancreas to the bowel lumen. The results of these experiments suggested that 
r 
the purified trypsin i,1hibitor is capable of exerting an acute effect on the pancreas 
via the bowel lumen. In view of its potential for actually inducing pancreatic 
enzyme synthesis as measured after a few days of feeding, it seemed l'ikely that 
the inhibitor was capable of stimulating enzyme synthesis and secretion after a 
single dose -. The pancreatic enlargement which occurs being a manifestation 
of repeated stimuli. For these reasons it was decided to assess the effects of a 
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17 5 
Part 2. Aims of Study 
The aims of this study .were twofold:- Firstly, to assess whether a 
preparatory dose of the purified soybean trypsin inhibitor potentiated 
75se -
selenomethionine uptake by the human pancreas; and secondly, to asse55 
whether this enhancement of the pancreatic scan, if it occurred, improved 
the diagnostic quality of the scan . 
177 
Part 3. Material and Methods 
1 7 8 
Sixty consecutive patients requiring pancreatic scans were chosen for 
inclusion in this study. Their classification according to the presence or 
absence of pancreatic disease is presented in Tobie 5. 'l . below:-
Table 5. 2 
Clinical Diagnosis of the Pancreatic State 











gastroenterostomy, etc. ) 8 
Total 60 
None of these patients are included in the study presented in Chapter 3. The 
state of the pancreas was determined clinically by a variety of biochemical and 
radiological procedures and in some cases at laparotomy. 
In order to ensure a meaningful assessment, the administration of the 
purified soybean trypsin inhibitor and the supervision of the scan was attended 
to by a single colleague who maintained a consistent preparatory protocol in 
all the patients. 
The purified soybean trypsin inhibitor was obtained commercially 
(Serevac Laboratories (PTY)Ltd., Maidenhead, Berks, England) in bulk and 
transferred in 50 mg. amounts to gelatin capsules for administration. 
1 7 9 -
The patient preparation was identical to that described in Chapter 3 
but in 30 of the 60 patients in this study 200 mgs. (4 capsules) of the purified 
trypsin inhibitor was given 1 to l ! hours before the 75Se - selenomethionine 
injection. In the order in which the scans were performed this was from patients 
number 11 to 40 . 
The scans were viewed at the end of the study by the author in a single 
session, without knowledge of any clinical detail or whether the patient had 
received purified trypsin inhibitor. Three observations were recnrded for each 
scan viewed:-
(i) The quality of the pancreatic impression i.e. whether excellent, 
good, fair ,,r poor; 
(ii) Whether the patient was likely to have had trypsin inhibitor (assum-
ing it to potentiate the 
75
Se - selenomethionine uptake) and . 
(iii) Whether the scan was normal or abnormal. 
1 8 0 
Part 4 . Results 
It was" impossible to anticipate which patients had received purified 
soybean trypsin inhibitor on the quality of the scan appearance. Of the 30 
patients who had received trypsin inhibitor only 11 patients were predicted 
as having had it. Seventeen patients out of the 30 in the control group 
were predicted to have hod it when in fact they hod not. 
There were 6 errors in diagnosis in the group of 60 patients, all 
amongst patients who were thought to have pancreatic disease clinically, 
but in whom the pancreas was passed as normal on the scan. One of this 
group was thought to have a carcinoma, the others to be suffering from acute 
or chronic pancreatitis. 
1 8 1 -
1 8 2 
Part 5. Discussion 
This controlled study indicates that under the conditions described 
a single dose of 200 mgs. soybean trypsin inhibitor does not influence the 
75
Se - selenomethionine uptake by the pancreas. The quality of the better 
pancreatic scans in both groups (Figs.5. I and 5. 2 .) is comparable 
1 8 3 
and it was found impossible to predict which patients had received the trypsin 
inhibitor capsules. As might be expected from this result the diagnostic 
accuracy was not influenced by whether or not the patient had received 
trypsin inhibitor. 
The overall accuracy of the scan reporting was 90% as there were 
6 erro11 out of 60 scans. The mistakes were al I made in the group of patients 
thought to have pancreatic disease clinically. However, it could not be 
sure that at the time of the scan pancreatic morphology and function was 
not in fact normal. 
The available experimental evidence suggests that the naturally occurr-
ing trypsin inhibitors are powerful inducers of the pancreatic digestive enzymes. 
It is not yet determined whether humans can respond to these substances as do 
rats or chickens. However the basic anatomical and functional similarities 
in the relationships of the upper gastro-intestinal organs and in the ultra -
structure of the pancreatic exocrine cell in a wide variety of avian and mam-
malian species (Caro and Palade, 1964) makes it likely that under the correct 
conditions they wi II respond similarly. 
There are three factors which may account for the negative results 
obtained in this study. Firstly, the quantity of trypsin inhibitor used may have 
been insufficient. The dose of 200 mgs. was arbitrarily chosen but the choice 
wos primarily influenced by the potency of the compound demonstrated in rat 
experiments (Table 5. I · ). Five to 10 times this amount may be a more 
realistic dose in humans. Secondly, the timing of the 
75
Se - selenomethionine 
1. 8 4 
. Fig .5.1: 
75 
- L - selenomethionine toscan of the 
abdomen in o patient who hod not received o 
of purified soybe n trypsin inhibitor . 
Isotope· uptake is excel lent and the g{a d appears 
normal . Th h of the ncreos is ccnti uous 
with but is not overlap d by t e livered 
Page li3 . 
Fi .5.2: A 
75Se - L - seleno t ionin photoicon of the 
bdomen in a patient who received 200 mgs. of 
purified soybe(n trypsin inhib"i'or orally, 1! hours 
before t e isotope injection . Isotope uptake 
throughout the 9land appears excellent. Ther is 
an rea of ~physiological" thinning between the 
he and toil of the pancreas. T head of the 
pancreas is only ma~inolly overlapped by the right 
lobe of the live,r. The quality of isotope uptake 
in this scan is com ruble to that .shown in fig .5 . 1. 
1 8 5 
injection in' ·relation to the preceding dose of trypsin inhibitor may not have 
been optimal. For example, in rats, maximum output of pancreatic enzymes 
occurs 3 to 6 hours after ingesting a diet supplemented by the soybean trypsin 
5 
inhibitor (Lyman and Lepkovsky, 1917). Therefore, it may be more realistic 
to give the 
75Se - selenomethionine injection 3 to 6 hours after the trypsin 
inhibitor instead of the 1 to 1 ! hours chosen for this study. finally, it may 
only be possible to demonstrate the effects of the naturally occurring trypsin 
inhibitor on the human pancreas after having increased the enzyme capacity 
of the pancreas by a suitable period of treatment with the inhibitor prior to 
scanning. Siegel, Jacobs, Studer and Potchen (1968) have shown in rats 
that an 8 day raw soybean diet augments the selenomethionine uptake by the rat 
pancreas twofold. If the ingestion of trypsin inhibitor does induce the synthe-
sis of digestive enzymes in the human pancreas, this approach would provide 
a rational solution to the problem of enhancement of the pancreatic scan. 
187 
Part 6. Conclusions 
1 8 8 
Measures such as supplementary protein· feeding·, 'secretin ·- pancreo·;_ . 
z·ymfn injections, amino - acid infusions, and !'}lOrphine and probanthine injec-
tions hove all foiled to produce a convincing improvement in the quality of 
the pancreatic scan. 
Dietary supplements of row soybean meal or the purifed trypsin inhibitor 
from a variety of biological sources such as soybean, ovomucoid or bovine 
pancreas, have been shown to be powerful inducers of pancreatic digestive 
enzyme synthesis in rats and chickens. 
A controlled trial has been undertaken to assess the effect of a single 
orally administered 200 mg. dose of purified soybean trypsin inhibitor on the 
pancreatic scan. It was concluded that under the conditions of this trial the 
trypsin inhibitor was without effect. 
In view of the failure of all preparatory techniques reported to enhance 
75
Se - selenomethionine uptake by the pancreas it is suggested that ~ rational 
approach to the problem would be through the induction of the pancreatic 
digestive enzymes by the continued administration of trypsin inhibitor for a 
period prior to performing the pancreatic scan. 
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The advent of a technique which may demonstrate the condition of 
the whole pancreas with minimal discomfort to the patient is a significant advance 
on the available techniques of pancreatic investigation. From the patient's 
point of view a pancreatic scan may avoid the discomfort of a preparatory fast, 
doodenal intubation or arterial puncture. The relative ease with which a 
pancreatic scan may be performed in any patient, particularly the sick, the aged 
and the anxious is probably its most outstanding advantage. 
It is difficult to compare the clinical value of the available techniques 
for pancreatic diagnosis primarily because of the widely differing conditions 
under which most reported studies have been conducted. The best established 
of the available pancreatic function tests is that described by Dreiling and 
Janowitz (1962) and involves the duodenal aspiration of pancreatic juice secreted 
in response to secretin and pancreozymin injection . While of value in estab-
lishing a diagnosis of chronic pancreatic insufficiency or carcinoma of the heed 
of pancreas diogncsis of more distal lesions in the body of the pancreas is gener-
ally poor with this technique. According to Dreiling and Janowitz the diag-
nostic accuracy in carcinoma of the pancreas falls from 95% in the head to 
3% in the tail . 
Cytological techniques in practised hands may also be of value . 
Raskin , Wenger, Sklar and Pleticka (1958) used cytological examination of 
secretin itimulatecl duodenal juice to make a correct diagnosis in 21 (63%) of 
34 patients with pancreatic cancer . Combining a secretin function test with 
cytological examination of the aspirated fluid may improve the diagnostic value 
of both tests considerably . In 60 patients with proven pancreatic carcinoma 
studied by Dreiling, Nieburgs and Janowitz (1960) 47 had positive cytology 
and 43 a positive (pathological) secretin test . Considering both tests together 
56 (95%) of the 60 patients were correctly diagnosed . We;ler and Raskin 
(1958) could establish the correct diagnosis in 89% of 35 patients with pan-
creatic carcinoma using both cytology and the secretin stimulation test. 
Assessed independently, the secretin test was abnormal in 75% and cytology 
in 62% of the patients. 
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Of the radiological techniques available, barium meal is widely used 
to screen patients for the presence of pancreatic carcinoma. The limitations 
of this technique in the diagnosis of pancreatic disease have been discussed in 
Chapter 1 • Besides the fact that the growth must be fairly large in order to be 
apparent, the signs are mostlt indirect and non - specific. like the secretin 
stimulation test the diagnostic accuracy diminishes from the head to the tail of 
the pancreas. In a retrospective survey of the routine interpretation of barium 
studies of the upper gastro - intestinal tract in 100 patients with proven pan-
creatic carcinoma (67 of the head, 26 of the body and 7 of the tail), Eyler, 
Clark and Rian (1962) found only 24 cases in whom a positive diagnosis had 
been made. In a controlled retrospective review of the same series by these 
authors, a positive diagnosis of "pancreatic enlargement" could only be made 
in 57 of the lOC coses studied. A comparative evaluation of the efficacy 
of arteriogrophy in demonstrating pancreatic lesions is very difficult to determine. 
Patients undergoing arteriography are a highly selected group in whom the 
clinical suspicion of neoplasia is usually very high. Because of the practical 
difficulties it is eery aifficult to embark on a prospective survey in order to 
establish its value as a diagnostic procedure in pancreatic disease. In exper-
ienced hands it is of undoubted value. In a limited study of 25 patients 
suffering from abdominal pain of obscure cause Meaney, Winkelman, Sullivan 
and Brown (1963) found 3 patients with arteriogrophic abnormalities thought to 
be due to pancreatic carcinoma. The diagnosis was confirmed in all 3 patients 
RoL 
at laparotomy. Baum,1; tinkelstein and Blakemore (1965) stress that the use of 
selective arteriography may be of particular value in selected patients, such as 
in those thought to be suffering from insulinoma in particular. Th~ tumours 
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have a rich vascularity and may be revealed by the "tumour blush 11 • However 
Ro., 
Baum, / Finkelstein and Blakemore consider that in view of the lack of voscu-
lority in the majority of carcinomas of the pancreas and the fact that the lesions 
must be of considerable size to cause recognisable vascular displacements, they 
do not feel optimistic about diagnosis of early pancreatic carcinoma by angio-
graphy. 
Considering the larger reported series of pancreatic scans in patients 
with pancreatic carcinoma, Sodee (1966) claimed a diagnostic accuracy of 96% 
in 26 patients. Brown, Sircus, Smith, Donoldson, Dymock, Falconer and 
Small (1968) reported the correct diagnosis in 93% of 14 patients. The worst 
result reported is that of Rodriguez - Antunez, Filson, Sullivan and Brown (1966) 
who diagnosed 41 patients as having carcinoma of the pancreas on the photoscan. 
These authors could subsequently only confirm 27 of the 41 "positive" scans 
i.e. they had . 34% fal1e positive1. In addition they mi1Sed 4 patients with 
carcinoma whom they thought were normal; The report by these authors suggests 
a general lack of appreciation of al I the variations of the normal and abnormal 
pancreatic scan. This state of affairs is very likely to lead to an over-diag-
nosis of pancreatic disease such as cancer. In the studies reported in this thesis, 
of the 100 patients' scans viewed without any knowledge of the clinical details 
(40 patients reported in Chapter 3 and 60 in Chapter 5), 10 were shown at 
laporotomy to have carcinoma. tn 8 of these 10 patients, the diagnosis was 
correctly made on the appearance of the scan alone. Pancreatic scanning 
compares favourably in diagnostic accuracy with th&. available techniques for 
the diagnosis of pancreatic carcinoma. With due consideratio~of its limita-
tions, it is likely that 
75
Se - selenomethionine pancreatic scanning will become 
a valuable screening technique in. helping the clinician to decide whether or 
not any patient has serious underlying pancreatic disease and in particular, 
carcinoma. 
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Like the more specialised radiological procedures which require costlier 
equipment, the newer scanning machin;s are also expensive. In addition the 
price of 
75
Se - selenomethionine is at present £40/mCi (The Radiochemical 
Centre, Amersham) in Britain. This averages approximately £10 per patient in 
the cost of the isotope alone. It wou Id seem that the expertise required for the 
most accurate interpreh:1tion of the pancreatic scan is similar to that of the 
radiologis.t interpreting a pancreatic angiogram. In both cases it is dependant 
on a proper appreciation of the .variations of the normal and the manner in which 
a variety of diseases may influence this pattern. Like most specialised proced-
ures therefore, the maximum information will be obtained from those units in 
which pancreatic scanning is performed as a regular service. In this way the 
cost of the scan and its potential hazards (radiation effects) will be well offset 
by the information it i1 likely to reveal concerning the state of the patients 
pancreas. 
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APPENDIX 1. 
ILLUSTRATIVE CASE H1ST0i1ES 
Normal Pancreas 
Patient No . 1 : A 51 year old woman who was admitted for the investigation 
of recurrent epigastric discomfort over 6 months. The discomfort was unrelated 
to meals and did not wake her up at night. She also complained of anorexia 
and the loss of 10 pounds in weight in the 3 months prior to admission. Besides 
appearing depressed the patient was quite normal on clinical examination. In 
particular, there was no visceromegaly or masses detectable on physical exam-
ination. The blood count was normal as were the blood urea, liver function 
tests, serum amylase, proteins and fasting blood sugar. · X-ray of chest, chole-
cystogram and barium meal were all quite normal. A 
75
Se - selenomethionine 
scan revealed a normal pancreas with excellent isotope uptake throughout the 
gland (Fig.3. o ). The patient was diagnosed as suffering from depression. 
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She was treated with amitryptylline and made an excellent recovery with prompt 
disappearance of the symptoms. She regained the weight l~t over 3 months and 
appeared in excellent health one year later on a follow-up examination, 6 months 
after discontinuing the tableb. 
Patient No.2: A 34 year old woman who was investigated for recurrent abdominal 
pain. A gastric ulcer was eventually diagnosed and the patient was submitted 
to partial gastrectomy. The pancreas was carefully inspected and found to be 
normal (Fig.3. S ). 
Patient No.3: A 38 year - old man in whom a pancreatic scan was performed 
in investigation of periodic epigastric discomfort. Clinical examination, blood 
count and barium meal were al I normal • The patient was reassured and discharged 
remaining quite well over 18 months on follow-up examination. (F,-, . 3. 6) 
Patient No.4: A 75 year - old woman who had become jaundiced one month 
before admission. She hod no abdominol pain and suffered no pruritis. There 
was no change in bowel habits though her stools had become pale and the urine 
darker since the onset of the jaundice. Clinically, the patient was opyrexial 
and there were no stigmata of chronic liver disease or portal hypertension. On 
abdominal examination, the liver was 3 ems. enlarged and slightly tender. 
There wen no splenomegaly. The serum bilirubin 8 mgs/(00 ml. (conjugated 
7 rng./100 ml.); alkaline phosphatase 60 K.A unif'VlOO ml.; aspartase trans-
aminase 27 i .u./1 ; cholesterol 590 mgs./100 ml.; increased x2 globulin 
on serum electrophoresis . Barium meal was normal and the pancreatic scan 
showed a normal pancreas of unusual configurations (Fig.3. 7 ). The jaundice 
faded throughout her admission and within 3 weeks the total serum bilirubin had 
fallen to 3.0 mgs./100 ml. Two months after discharge the patient was 
anicteric with a total serum bilirubin of 1 .2 mgs./100 ml. The clinical diag-
nosis was cholestatic hepatitis though cholelithiasis could not be excluded. 
There was no history of drug ingestion. 
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Carcinoma of the Pancreas 
Patient No.5: (Fig.3. ta ). A 72 year - old man who gave a 7 week history 
of malaise, anorexia, loss of weight and increasing jaundice. Clinically it was 
not possible to palpate a gallbladder. The serum bilirubin was 25 mg./100 ml. 
(conjugated bilirubin 19 .5 mg./100 ml.) and the alkaline phosphatase was 
65 K.A. units/100 ml. A barium meal showed a duodenal ulcer. The duodenal 
loop appeared normal. At laporotomy a 3 cm. diameter carcinoma was detected 
as depicted on the scan • 
Patient No.6: (Fig.3. 12. ). A 52 year - old man with a 9 month history of 
low backache which was followed by 3 months epigastric pain. Four weeks 
before admission the patient developed jaundice with pole stools and dark urine. 
On physical examination there was no visceromegaly or masses detected in the 
abdomen. The serum bilirubin was 5.6 mg./100 ml. (conjugated bilirubin 
4.0 mg./100 ml.) and the alkaline phosphatase was40 K.A.units/100 ml •• 
A laporotomy revealed a large carcinoma of the pancreas involving the head, 
neck and body and extending into the portal vein. 
Patient No.7: This 36 year - old woman had suffered backache in the region of 
the 1st. lumbar vertebra for 2 years. for 5 months before admission it had rad-
iated round both subcostal regions and for 2 months it had been particularly 
intractable and severe. Clinically the patient was a frail woman who appeared 
depressed and in pain. A hard immoveable mass was palpated in the epigastrum. 
The serum alkaline pho_sphatase was 33 K.A.units/100 ml. The serum amylase, 
bilirubin blood sugar, cholesterol and protein estimations were all normal. A 
barium meal showed some flattening of the medial margin of the second part of 
the duodenum. The pancreatic scan (Fig.3. 13 ) was suggestive of carcinoma 
of the body of the pancreas. This was confirmed at laporotomy by biopsy as 
the lesion was unresectoble. 
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Zollinger - Ellison Syndrome 
Patient No.8: A 52 year - old male with a 6 year history of recurrent bouts 
of epigastric pain lasting up to 3 days and unrelated to food, alcohol or posture. 
For about the same period he had diarrhoea of varying severity, the stools being 
pale and watery. Four years previous to admission a diagnosis of "jejunitis" 
had been made on the basis of a barium meal. Clinically the patient was thin 
with the signs of chronic bronchitis and emphysema. No visceromegaly or 
masses were detected on abdominal examination. The faecal fat level varied 
between 14 to 26 g per day. The serum alkaline phosphatase was 29 K.A.units/ 
100 ml. but there was no evidence of Pagets disease. The oral glucose toler- • 
ance test using a standard 50 g glucose load showed moderate impairment with 
levels of 90, 180, 190, 120, 100 mg. /100 ml. at zero, 30, 60, 90, and 120 
minutes respectively. The serum amylase, calcium, phosphorus, urea; electro-
lytes and protein were all normal. A secretin stimulation test ( 1 u/kg. Boots 
secretin intravenously) gave a volume output of 2.2 ml. /kg. body weight and 
a bicarbonate content of 17 mEq. /1. An augmented Histalog test ( 2 mg. /kg. 
body weight) showed a basal acid secretion of 24 mEq. /hour and a maximum 
response of 50 mEq. /hour. Jejuna! biopsy showed a normal mucosal morphology. 
The patient was diagnosed as having the Zollinger - Ellison syndrome and chronic 
pancreatitis. At laparotomy a small 1 cm. diameter nodule was felt in the tail 
of the pancreas. A two-thirds distal pancreatectomy was performed. On 
sectioning the nodule proved to be a small cyst but histology of the surrounding 
tissue showed considerable coarse and fine fibrosis with distortion of many of 
the ducts. Small groups of carcinoma cells in clumps and lines as well as single 
cells were present within the fibrous tissue. On the basis of their staining 
properties these carcinoma eel Is were thought to be derived from the o<- eel Is 
of pancreatic islets. 
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A Histalog test repeated 25 days aft'er the operation showed ·a basal 
acid output of 5 mEq. /hour. The faecal fat had decreased to 8 g per day on 
a normal diet and there was no diarrhoea. A repeat scan 4 months after the 
operation showed complete disappearance of the area of increased uptake (Fig . 3. 11,.ft. 
· No gastrin-like activity could be demonstrated on an extract of the tumour tissue. 
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Acute Pancreatitis: 
Patient No. 9: A 76 year - old man who in 1966 underwent laparotomy for a 
severe bout of sudden abdominal pain and was found to be suffering from acute 
pancreatitis. His blood amylase postoperatively was 10,600 u /100 ml. • A 
cholecystectomy was performed at this operation because of the presence of gal 1-
stones. A pancreatic scan was performed 10 days postoperatively ( Fig.3.ID4). 
The patient was rescanned 10 months later after full clinical recovery and no 
further attacks (Fig.3.IOb ). 
Patient No.10: A 25 year - old man with a 7 week history of deepening 
jaundice with pale stools and dark urine. At the onset of this illness the patient 
had recurrent bouts of upper abdominal pain associated with anorexia and malaise. 
Clinically he was mildly icteric. The liver edge was palpable in the epigastrum. 
Biochemical investigation and liver biopsy suggested large-duct obstruction and 
because of an exacerbation of the abdominal pain a laparotomy was performed. 
At operation the duct system was dilated. This was due to a gallstone impacted 
at the Ampulla of Vater. The pancreas head was swollen and inflamed. The 
stone was removed via a sphincterotomy, a cholecystectomy was performed and 
the patient made an excellent postoperative recovery. (f'ta, 3.l5) 
Patient No. 11 : A 34 year - old man who had suffered 3 severe attacks of acute 
pancreatitis over 4 years. On each occasion he had abdominal pain and vom-
iting. A laparotomy was performed during the third attack as the vomiting was 
so severe that high intestinal obstruction was feared. The pancreas was found 
to be swollen and inflamed with numerous adhesions between it and adjacent 
viscera. A scan ·performed 4 weeks later (Fig.3.tlf. ) showed a filling defect 
in the body of the pancreas. On the strength of this scan appearance re-explor-
ation was advised as it was feared that a carcinoma may have been missed in 
the inflamed pancreas. A laparotomy 3 months later confirmed the presence of 
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a necrotic area in the body of the pancreas. This was excised and the pancreas 
anastomosed to a loop of jejunum. Histological examination of the excised tissue 
showed only necrotic pancreas with obliterated arterioles but no evidence of 
cancer. The patient made cm uneventful recovery and has remained well for 3 
months following the operation. 
The cause of the pancreotitis has remained obscure. There was no signi-
ficant history of alcohol intake, no gall-stones were detected during the most 
recent laparotomy and the serum calcium was normal • 
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Chronic Pancreatitis 
Patient No.12: A 56 year - old man who was diagnosed as suffering from 
diabetes mellitus due to chronic pancreatitis in 1962. This was thought to be 
alcoholic in origin as he professed to a very high spirits intake over the preceding 
20 years. In 1967 he had a recurrence of severe abdominal pain following a 
bout of drinking. Abdominal x-roy at this time revealed calcification of the 
pancreas (Fig. 3. U, I:, ) • A scan performed 3 weeks after this attack showed a 
small island of activity in the head of the pancreas alone (Fig.3. Uu~). At this 
stage his blood amylase and calcium levels were normal but his fasting blood sugar 
was elevated (2.50 mgs. /100 ml.) and required insulin injections for control. 
203 
Pseudopancreatic Cyst 
Patient No.13: A 48 year - old man who was known to have cryptogenic 
cirrhosis of the liver with portal vein thrombosis and portal hypertension. · The 
patient suffered from recurrent bouts of haematemesis and malaena due to bleeding 
oesophageal varices. He was submitted to laporotomy in an attempt to perform 
a spleno - renal shunt. At operation the spleen was mobi I ized and a splenectomy 
was performed. The operation was then abandoned because of extensive bleeding. 
Postopervtively the patient developed a discharging sinus in theJeft flcmk which 
was diagnosed as a pancreatic fistula. Radio - opaque dye injected through a 
catheter in the sinus was shown to pool behind the stomach (Fig.3. If,-). The 
fistula stopped discharging about 8 weeks postoperatively. Two weeks later he 
developed an epigastric mass. A barium meal showed an indentation of the 
greater curve of the stomach (Fig.3.181,) and this approximated to the area of 
increased uptake on the pancreatic scan (Fig.3. 11 ). 
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Diabetes Mellitus 
Patient No.1 4: A 67 year - old woman in whom diabetes mellitus was diagnosed 
2 years prior to admission and controlled on isophane insulin. Seven months 
before admission diabetic control became progressively more difficult and the 
patient suffered frequent hypoglycaemic attacks. These persisted even when the 
patient was given soluble insulin. Extensive clinical, radiological and bio-
chemical investigation failed to show pancreatic pathology. At laparotomy the 
pancreas appeared normal and the relationships depicted on the scan were con-
firmed (Fig.3. 'I ) . 
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Peptic Ulcer 
Patient No.15: A 73 year - old man who was submitted to laparotomy because of 
long standing indigestion and epigastric pain which had become intractable. 
(Language difficulties made an accurate history impossible). At laparotomy he 
was found to have o chronic duodenal ulcer in the upper part of the second port 
of the duodenum. Related to this, and compreuing and distorting the neck of the 
pancreas (Fig.3. 20 ) was a large mass of mesentery and numerous adhesions. 
The picture was thot of a subacute perforation of the duodenal ulcer. The head 
and body of the pancreas felt normal. A vagotomy and gastro -jejunostomy WIIS 
performed. 
Patient No. 16: A 42 year - old man who had been treated for recurrent bouts 
of dyspepsia due to duodenal ulcer for 8 years. Two years-prior to admission a 
repeat barium meal showed a gastric ulcer. Five weeks before admission the 
patient developed an exacerbation of abdominal pain which became more persistant 
and tended to radiate through to the back. Because he improved very little on 
intensive conservative therapy over 3 weeks he was submitted to laporotomy. 
The presence of both a gastric and duodenal ulcer was confirmed. The gastfi,c 
ulcer, situated on the posterior wall of the stomach was attached to the tail of the 
pancreas by fibrous tissue. The tail had been pulled upwards and displaced by 
contraction of the fibrous tissue (Fig.3. l'f ). The signs were those of chronic 
perforation of a gastric ulcer with involvement of the tail of the pancreas. The 
pancreas was dissected free and a Billroth I gastrectomy and vagotomy were per-
formed. The patient made an uneventful recovery. 
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Aortic Aneurysm 
Patient No. 17: A 76 year - old woman who presented with a 5 month history of 
epigastric pain radiating through to the back. Eleven months prior to admission 
the patient had been treated at another hospital for unexplained iron deficiency 
anaemia. Besides some epigastric tenderness there were no other clinical signs 
of note. Barium meal revealed a sliding hiatus hernia but no lesion was seen in 
the stomach or duodenum. The glucose tolerance test was normol. Pancreatic 
scan showed a filling defect in the body of the pancreas (Fig .3. 2, I ) . As her 
symptoms had not improved after 4 weeks of intensive alkali and anticholinergic 
treatment the patient underwent laparotomy. At laparotomy the hiatus hernia 
was repaired. She was found in addition to have a fairly large fusiform aneurysm 
of the aorta displacing the body of the pancreas anteriorly. The pancreas appear
ed 
quite normal on examination. 
Patient No. 18: A 66 year - old female with a history of recurrent severe epi-
gastric pain and vomiting for a year. Physical examination was non-contributory
. 
A barium meal showed a large incarcerated hiatus hernia with free reflux in the 
supine position. At operation the pancreas appeared quite normal but was dis-
placed upwards by a saccular aneurysm of the aorta as depicted on the scan 
(Fig.3. Z.1 ). 
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Fibrocystic Disease of the Pancreas 
Patient No. 19: (Page f03 ) • A 16 year - old girl who at the age of 5 years 
started developing recurrent respiratory infections. A diagnosis of bronchiec-
tasis was mode at 6 years. After developing steatorrhoea at 7 years the diag-
nosis of fibrocystic disease of the pancreas was established. Over the next 2 
years the patient had several haematemeses and she was noted to have spleno-
megaly on examination. Liver biopsy revealed cirrhosis and portal hypertension 
with bleeding from oesophageal varices was diagnosed. The patient continued 
to have recurrent haematerneses and by the age of 16 years had had several 
hospital admissions because of this. Her chest also continued to prove troublesome 
and she had an almost continuous cough with the production of large volumes of 
purulent sputum. After a particularly severe bout of haematemesis she was admitted 
for resuscitation and palliative surgery. At laparotomy a spleno - renal anastom-
osis was perfonned because the portal vein was found to be thrombosed. Post-
operatively a series of recurrent respiratory crises supervened and despite antibiotic 
therapy, bronchoscopy with bronchial lavage, tracheostomy and oxygen therapy 
she went progressively downhill and died on the tenth postoperative day. 
At post - mortem there were widespread bronchopneumonic changes. The 
liver showed a mainly macronodular cirrhosis with considerable fatty change. 
Viscid bile was present in a few ductules. Most of the pancreas was replaced by 
fat. Ducts were di lated containing mucinous secretion. They were surrounded 
by fibrous tissue. The islets were relatively well preserved. These autopsy 
changes were considered to be consistent with the diagnosis of fibrocystic disease 










Patient No. 20: (Page 103 ) • A 63 year - old man whose i I lness began 6 months 
before his death with sharp, stabbing pains in both legs. Associated symptoms 
at the onset included anorexia and lassitude. These wore off within a few weeks ' ' l I 
but the limb pains continued to progress as did the accompanying muscular weak-
ness. The legs were worst affected but the weakness and-wasting.ascended to . 
involve the trunk and upper limbs. Body dysaesthesia was an, outstanding symptom 
~hich bt,came progressively ~orse as the weeks ~sed. This eventually became 
so painful and unpleasant that the pc;,tient preferred t~ dry h,imself after ~ bath by 
standing in front of the heater, rather than rub his skin with a towel. There was 
no family history of nervous dieose. On clinical examination the patient when 
seen 3 months after onset of the illr,ess appeared emaciated and ~epressed. 
Examination of the nervous system revealed some loss of power in all limbs, more 
marked proximally than distally,with greatly diminished tendpn jerks. All 
modalities of sensation were iotQCt as were the cranial nerves. All other systems 
appeared normal. The blood count was normal as were the blood urea and 
electrolytes, liver function tests, serum proteins and electrophoretic strip. The 
glucose tolerance test showed slight impairment with a fasting b_lood sugar of 
94 mgs./100 ml. and a 2 hour level of 110 mgs./100 ml. after a 50 g oral 
glucose load. Liver biopsy showed a moderately thickened arteriole which 
stained positively for omyloid with Congo Red. Similar changes were detected 
in a duodenal biopsy. The patient's condition continued to progress rapidly. 
In spite of extensive investigation no cause for the omyloidosis could be found and 
he died 6 months ofter the onset of the i I lness. At autopsy there was amyloid 
infiltration of the heart, liver, adrenals, spleen, pancreas, thyroid, tongue and 
peripheral nerves. In the pancreas there was extensive vascular and acinar 
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Appendix l wo 
(Prepared with the assistance of Mr. J.E. Agnew, M.Sc •• ) 
Radiation Dosimetry of Se
75 
- Selenocystine 
The evidence presented in Chapter 4 shows that, for dosimetry purposes, 
a dose of 4 JA CV Kg. body weight of Se75 - selenocystine may be treated as 
equivalent to the sum of: 
(i) 2 ~Ci/Kg. of Se
75 
excreted rapidly via the kidneys. For calculation 
purposes the half-time in the kidneys of this component may be taken as 10 hours -
although the experimental evidence suggests that the true figure is probably 
rather less. 
(ii) 2 t4 Ci/Kg. of Se
75 
treated metabolically in the same way as after 
d · · · · h c f S 
75 I h. · a man1strat1on in t e Torm o e - se enomet 1onane. 
, .... 
Radiation Dosage D'wa to Component (i) 
(a) To kidneys 
The gamma dose is given by -
= 0.0346..;0 ,- g Co Teff r (Ref. 1) 
Where the meaning and valueso£·,the symbols are as follows:-
/0 = density of tissue (may be taken as 1 ) • 
r = specific gamma ·- ray constant - approximately 1 .8 /mCi 
75 
ot 1 cm. for Se (Ref. 2 ) 
g = mean geometrival factor - approximately 25 for the kidney 
(Ref. 3 ) 
,. 
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Co = initial concentration of Se
75 
in kidney. It may be assumed 
that about 1 f-A Ci/Kg. goes to each kidney, i.e. 70 t' Ci 
per kidney for a standard 70 Kg . man. In a standard man, 
the kidney has a masa of 300 gm. ( ef. 4 ) 
Thus Co =~ JA Ci/gm . 
Teff = effective half - life = 10 hours. 
Using these values, together with a roentgen - to - rod conversion factor 
of O. 97 (Ref. 5 ) we get 
Di = 3.5 rad. 
The beta dose ( 0 f!i ) is given by 
D 13 = 73.8 E~ Co Teff rads 
Where r ~ = mean beta - ray energy per disintegration 
0 .019 MeV/dis for Se
75 
(Ref. 2 ) 
Thus D_,_~~~=~3~·~3~rad~. 
Total dose to kidney from component (i) = 6.8 rad 
(b) lo pancreas 
Difficult to evaluate exactly but certainly much less than from 
component (ii); i .e. much less that 0.4 rad (see below). 
(c) To Liver 
Comparatively negligible from this component. 
(d} To whole Body 
The same formulce are used as in (a) and the same Teff assumed. For a 
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standard 10 Kg .· man g may be taken as 126 (Ref . 1 ) • For a 2 t' Ci/ Kg . 
dose Co is 2 x 10-3 y.. Ci/ gm . 
thus Dt = 0 . 15 n:acl 
and 0 ~ = 0 .03 rad 
i.e. Total whole - body dose from component (i) = 0. 18 rad. 
Radiation Dosage Due to Component (ii) 
The values below are based on work by Sodee (Ref. 3 ) - adjusted 





To kidneys 8 .1 rad 
To pancreas 0.4 n 
To liver 0.1 II 
To whole - body 1.3 11 
Radiation Dosage Due to 4 e Ci/Kg . of 
Se
75 
- Selenocystine ( (i) + (ii) ) 
75 COM.f'e>.l'ecJ. 
The dosage due to Se - selenocystine is shown below, COAl"'9ated 
with that due to 3 1'- Ci/Kg. of Se
75
- Selenomethionine. 






Kidneys 15.0 rads 12.0 rads 
Pancreas 0.8 II 0.6 
II 
liver 0.1 II 0. 2 
II 




- selenocystine, the radiation dosage to the ovary and 
testes should not be significantly greater than with Se
75 
- ,elenomethionine . 
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Au-Colloidal Gold Liver Scan (Fig .3. ) • 
Rationale: 
In the liver the colloidal gold is taken up and retained indefinately 
by the Kupffer cells (McAfee, Ause and Wagner, 1965). Liver uptake is 
therefore quite independent of liver cell function. One of the earliest studies 
on the distribution of intravenosuly administered 
198
Au - colloidal gold in 
man and dogs WO$ performed by Sheppard, Wells, Hahn and Goodell (1947). 
These autho11 showed that the distribution of activity was high in liver and 
spleen, intermediate to low .in the kidney and low in other organs. In studying 
the tumour localization of intravenously administered 
198Au-colloid gold in 
man, Root, Andrews, Kniseley and Tyor (1954) estimated that normal liver tissue 
probobly contained 60 to 94% of the dose, spleen 5 to 16%, kidneys 0.05 to 
0 .24% and lungs 0. 8 to 3.2%. Although there was a large error in estimating 
the total bone-marrow content it was calculated that it may contain total amounts 
of the i10tope in the same range as the quantities in the spleen. These studies 
helped establish the fact that there was reticulo-endothelial uptake of the syst-
emically administered 
198
Au colloidal gold. 
This clearance of colloidal gold is very rapid and Christie, MacIntyre, 
Crespo, and Koch-Weser (1963) have estimated that in normal people less than 
10% remains in the blood after 10 minutes. However in patients suffering from 
advanced cirrhosis with impaired liver blood flow it may take 30 minutes to 
achieve similar blood levels. An important consequence of the reduced hepatic 
clearance of colloidal gold in cirrhosis is that the compound is deposited in 
greater amounts at other sites such as the bone-marrow and s~leen. 
Dosimetry of 
198 
Au-Colloidal Gold in Man 
For practical purposes hepatic clearance of colloidal gold is so efficient 
that only the radiation dose received by the liver is considered in these cal-
culations. It is estimated by Quimby (1960) that a 2Kg . liver will receive a 
radiation dose of 5.7 rad from 150 Ci 
198Au. Quimby considers that as the 
average annual dose of 15 rad is applicable, this amounts to about 4 rads per 
quarter or a permissible injection of 100 Ci of 
198 
Au. She concludes that 
"the higher dose of 150 Ci ma.y be justified on the basis of medical desirability 
of the information and the impossibility of obtaining it with smaller doses". 
The patients in the 
75
Se - selenomethionine studies (Chapters 3 & 5) 
received a standard 110 to 130 Ci dose of 
198
Au - colloidal gold as this 
produced a consistently accurate hepatic image. 




Au - colloidal gold was supplied by "The Radiochemical Centre" , 
Amersham. The isotope generally required dilution before administration but 
the volume varied due to the short haif-life of 
198
Au (2.7 days). 
The liver scan was commenced 10 to 30 minutes after injection of the 
isotope and lasted 20 to 25 minutes. The scanner was readjusted to the optimum 
settings for 
198
Au (Chapter 2) and the collimator run at 60 cm./minute . To 
facilitate comparison between the pancreatic and liver scans, the same surface 
markings were utilized for both . 
Results 
In keeping with the experience of Whang, Fish and Pollycove (1965) 
the hepatic scan gave an accurate representation of the true position of the 
217 
liver edge as detennined clinically. 
There was very little discerable splenic uptake unless the liver was 
diseased. In advanced liver disease, particularly in cirrhosis, splenic uptake · 
was considerably enhanced and marrow uptake (sternum and spine) was sometimes 
evident. Splenomegaly per se was not associated with 
198 
Au - colloidal 
gold uptake. 
The finding of 
75
Se - selenomethionine uptake in the area of the spleen 
as judged by the 
198
Au - colloidal gold scan was a rare event. When it 
occurred it was invariably in the preaence of splenomegaly and was thought to 
be a consequence of increased splenic vascularity rather than splenic utilization 
of 
75
Se - selenomethionine. 
The correspondence between the liver scans with 
75
Se - selenomethionine 
and 
198 
Au - colloidal gold was excellent and defects in one were almost 
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